<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0"
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main" xml:id="_yWguY5q">The effect of physical activity on mortality and cardiovascular disease in 130 000 people from 17 high-income, middle-income, and low-income countries: the PURE study</title>
				<funder>
					<orgName type="full">Medical Research Council of SA, South Africa</orgName>
				</funder>
				<funder>
					<orgName type="full">Netherlands Programme for Alternative Development)</orgName>
				</funder>
				<funder>
					<orgName type="full">Novartis</orgName>
				</funder>
				<funder>
					<orgName type="full">GSK</orgName>
				</funder>
				<funder>
					<orgName type="full">National Research Foundation</orgName>
					<orgName type="abbreviated">NRF</orgName>
					<idno type="DOI" subtype="crossref">https://doi.org/10.13039/501100001321</idno>
				</funder>
				<funder>
					<orgName type="full">King Gustaf V</orgName>
				</funder>
				<funder>
					<orgName type="full">Palestinian territory</orgName>
				</funder>
				<funder>
					<orgName type="full">Metabolic Syndrome Society</orgName>
				</funder>
				<funder>
					<orgName type="full">AFA Insurance, Sweden</orgName>
				</funder>
				<funder>
					<orgName type="full">Boehringer Ingelheim (Germany and Canada)</orgName>
				</funder>
				<funder>
					<orgName type="full">Public Health Agency of Canada</orgName>
					<orgName type="abbreviated">ASPC</orgName>
					<idno type="DOI" subtype="crossref">https://doi.org/10.13039/100011094</idno>
				</funder>
				<funder>
					<orgName type="full">Pfizer/Heart</orgName>
				</funder>
				<funder>
					<orgName type="full">Sweden</orgName>
				</funder>
				<funder>
					<orgName type="full">Champlain Cardiovascular Disease Prevention Network, Canada</orgName>
				</funder>
				<funder>
					<orgName type="full">King Pharma</orgName>
				</funder>
				<funder>
					<orgName type="full">Sheikh Hamdan Bin Rashid Al Maktoum Award For Medical Sciences and Dubai Health Authority, Dubai, United Arab Emirates</orgName>
				</funder>
				<funder ref="#_b7bBkU8">
					<orgName type="full">Deanship of Scientific Research at King Saud University, Riyadh, Saudi Arabia</orgName>
				</funder>
				<funder>
					<orgName type="full">Swedish Research Council, Sweden</orgName>
				</funder>
				<funder>
					<orgName type="full">Ontario Ministry of Health and Long-Term Care</orgName>
				</funder>
				<funder ref="#_98QbWwh">
					<orgName type="full">Universiti Teknologi MARA, Universiti Kebangsaan, Malaysia</orgName>
				</funder>
				<funder>
					<orgName type="full">Heart and Stroke Foundation of Ontario</orgName>
				</funder>
				<funder>
					<orgName type="full">South Africa</orgName>
				</funder>
				<funder>
					<orgName type="full">SA Sugar Association (SASA)</orgName>
				</funder>
				<funder>
					<orgName type="full">Swedish Council for Health, Sweden, Working Life and Welfare, Sweden</orgName>
				</funder>
				<funder>
					<orgName type="full">Queen Victoria Freemasons Foundation, Sweden</orgName>
				</funder>
				<funder ref="#_aCJhZk9">
					<orgName type="full">Polish Ministry of Science and Higher Education</orgName>
				</funder>
				<funder>
					<orgName type="full">North-West University</orgName>
				</funder>
				<funder>
					<orgName type="full">Västra Götaland Region (FOUU)</orgName>
				</funder>
				<funder>
					<orgName type="full">Strategy for Patient-Oriented Research</orgName>
					<orgName type="abbreviated">SPOR</orgName>
					<idno type="DOI" subtype="crossref">https://doi.org/10.13039/100021570</idno>
				</funder>
				<funder ref="#_ZjVWYZb">
					<orgName type="full">National Center for Cardiovascular Diseases, China</orgName>
				</funder>
				<funder>
					<orgName type="full">Sanofi-Aventis (France and Canada)</orgName>
				</funder>
				<funder ref="#_6Qpd4p5">
					<orgName type="full">Ministry of Science, Technology and Innovation of Malaysia</orgName>
				</funder>
				<funder>
					<orgName type="full">Independent University, Bangladesh</orgName>
				</funder>
				<funder>
					<orgName type="full">Canada</orgName>
				</funder>
				<funder>
					<orgName type="full">AstraZeneca, Turkey</orgName>
				</funder>
				<funder>
					<orgName type="full">Mary W Burke</orgName>
				</funder>
				<funder>
					<orgName type="full">Indian Council of Medical Research, India</orgName>
				</funder>
				<funder ref="#_vS68TXk">
					<orgName type="full">Ministry of Higher Education of Malaysia</orgName>
				</funder>
				<funder>
					<orgName type="full">Swedish Heart and Lung Foundation, Sweden</orgName>
				</funder>
				<funder ref="#_aU7Fpy8">
					<orgName type="full">Population Health Research Institute</orgName>
				</funder>
				<funder>
					<orgName type="full">AstraZeneca (Canada)</orgName>
				</funder>
				<funder>
					<orgName type="full">Stroke Foundation Chair in Cardiovascular Prevention at St Paul&apos;s Hospital</orgName>
				</funder>
				<funder>
					<orgName type="full">Universidad de la Frontera</orgName>
				</funder>
				<funder>
					<orgName type="full">Swedish Council for Working Life and Social Research, Sweden</orgName>
				</funder>
				<funder>
					<orgName type="full">Agreement concerning research and education of doctors</orgName>
				</funder>
				<funder>
					<orgName type="full">Sanofi-Aventis</orgName>
				</funder>
				<funder>
					<orgName type="full">Philippine Council for Health Research &amp; Development</orgName>
					<orgName type="abbreviated">PCHRD</orgName>
				</funder>
				<funder>
					<orgName type="full">Turkey</orgName>
				</funder>
				<funder>
					<orgName type="full">Mitra and Associates, Bangladesh</orgName>
				</funder>
				<funder>
					<orgName type="full">Unilever Health Institute, Brazil</orgName>
				</funder>
				<funder>
					<orgName type="full">South Africa, Faculty of Community and Health Sciences (UWC), South Africa</orgName>
				</funder>
				<funder>
					<orgName type="full">Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning, Sweden</orgName>
				</funder>
				<funder ref="#_PRQrgXh">
					<orgName type="full">United Nations Relief and Works Agency for Palestine Refugees in the Near East</orgName>
					<orgName type="abbreviated">UNRWA</orgName>
				</funder>
				<funder>
					<orgName type="full">Canadian Institutes of Health Research, Heart and Stroke Foundation of Ontario</orgName>
				</funder>
				<funder>
					<orgName type="full">International Development Research Centre</orgName>
					<orgName type="abbreviated">CRDI</orgName>
					<idno type="DOI" subtype="crossref">https://doi.org/10.13039/501100000193</idno>
				</funder>
				<funder>
					<orgName type="full">Swedish state under (LäkarUtbildningsAvtalet) Agreement</orgName>
				</funder>
				<funder>
					<orgName type="full">Servier</orgName>
				</funder>
				<funder>
					<orgName type="full">Wroclaw Medical University, Poland</orgName>
				</funder>
				<funder>
					<orgName type="full">Ontario SPOR SUPPORT Unit</orgName>
					<orgName type="abbreviated">OSSU</orgName>
					<idno type="DOI" subtype="crossref">https://doi.org/10.13039/100023459</idno>
				</funder>
				<funder>
					<orgName type="full">Fundacion ECLA</orgName>
				</funder>
				<funder>
					<orgName type="full">SANPAD (SA</orgName>
				</funder>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author role="corresp">
							<persName><roleName>Dr</roleName><forename type="first">Scott</forename><forename type="middle">A</forename><surname>Lear</surname></persName>
							<email>slear@providencehealth.bc.ca</email>
							<affiliation key="aff10">
								<note type="raw_affiliation"><label>A</label> PhD) ; Dante Pazzanese Institute of Cardiology , São Paulo , Brazil (</note>
								<orgName type="department">PhD)</orgName>
								<orgName type="institution">Dante Pazzanese Institute of Cardiology</orgName>
								<address>
									<settlement>São Paulo</settlement>
									<country key="BR">Brazil</country>
								</address>
							</affiliation>
							<affiliation key="aff10">
								<note type="raw_affiliation"><label>A</label> PhD) ; Dante Pazzanese Institute of Cardiology , São Paulo , Brazil (</note>
								<orgName type="department">PhD)</orgName>
								<orgName type="institution">Dante Pazzanese Institute of Cardiology</orgName>
								<address>
									<settlement>São Paulo</settlement>
									<country key="BR">Brazil</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Weihong</forename><surname>Hu</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Sumathy</forename><surname>Rangarajan</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Danijela</forename><surname>Gasevic</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Darryl</forename><surname>Leong</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Romaina</forename><surname>Iqbal</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Amparo</forename><surname>Casanova</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Sumathi</forename><surname>Swaminathan</surname></persName>
						</author>
						<author>
							<persName><forename type="first">M</forename><surname>Anjana</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Rajesh</forename><surname>Kumar</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Annika</forename><surname>Rosengren</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Li</forename><surname>Wei</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Wang</forename><surname>Yang</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Wang</forename><surname>Chuangshi</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Liu</forename><surname>Huaxing</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Sanjeev</forename><surname>Nair</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Rafael</forename><surname>Diaz</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Hany</forename><surname>Swidon</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Rajeev</forename><surname>Gupta</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Noushin</forename><surname>Mohammadifard</surname></persName>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Patricio</forename><surname>Lopez-Jaramillo</surname></persName>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Aytekin</forename><surname>Oguz</surname></persName>
							<affiliation key="aff10">
								<note type="raw_affiliation"><label>A</label> PhD) ; Dante Pazzanese Institute of Cardiology , São Paulo , Brazil (</note>
								<orgName type="department">PhD)</orgName>
								<orgName type="institution">Dante Pazzanese Institute of Cardiology</orgName>
								<address>
									<settlement>São Paulo</settlement>
									<country key="BR">Brazil</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Katarzyna</forename><surname>Zatonska</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Pamela</forename><surname>Seron</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Alvaro</forename><surname>Avezum</surname></persName>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Paul</forename><surname>Poirier</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Koon</forename><surname>Teo</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Salim</forename><surname>Yusuf</surname></persName>
						</author>
						<author>
							<affiliation key="aff0">
								<note type="raw_affiliation">Funding Population Health Research Institute , the Canadian Institutes of Health Research , Heart and Stroke Foundation of Ontario , Ontario</note>
								<orgName type="department">Funding Population Health Research Institute</orgName>
								<orgName type="institution" key="instit1">Canadian Institutes of Health Research</orgName>
								<orgName type="institution" key="instit2">Heart and Stroke Foundation of Ontario</orgName>
								<address>
									<region>Ontario</region>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff1">
								<note type="raw_affiliation">SPOR Support Unit , Ontario Ministry of Health and Long-Term Care , AstraZeneca , Sanofi-Aventis , Boehringer Ingelheim , Servier , GSK , Novartis , King Pharma , (L Huaxing) ; Government Medical College , Trivandrum , India (S</note>
								<orgName type="department" key="dep1">Ontario Ministry of Health and Long-Term Care</orgName>
								<orgName type="department" key="dep2">L Huaxing</orgName>
								<orgName type="institution" key="instit1">SPOR Support Unit</orgName>
								<orgName type="institution" key="instit2">AstraZeneca</orgName>
								<orgName type="institution" key="instit3">Sanofi-Aventis</orgName>
								<orgName type="institution" key="instit4">Boehringer Ingelheim</orgName>
								<orgName type="institution" key="instit5">Servier</orgName>
								<orgName type="institution" key="instit6">GSK</orgName>
								<orgName type="institution" key="instit7">Novartis</orgName>
								<orgName type="institution" key="instit8">King Pharma</orgName>
								<orgName type="institution" key="instit9">Government Medical College</orgName>
								<address>
									<settlement>Trivandrum</settlement>
									<region>S</region>
									<country key="IN">India</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff2">
								<note type="raw_affiliation">Nair MD) ; Estudios Clinicos Latinoamerica ECLA , Rosario , Santa Fe , Argentina (R Diaz MD</note>
								<orgName type="department">Nair MD)</orgName>
								<orgName type="institution">Estudios Clinicos Latinoamerica ECLA</orgName>
								<address>
									<settlement>Rosario Santa Fe</settlement>
									<region>R Diaz MD</region>
									<country key="AR">Argentina</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff3">
								<note type="raw_affiliation">) ; Dubai Medical College , Dubai Health Authority , Dubai , United Arab Emirates (</note>
								<orgName type="department" key="dep1">Dubai Medical College</orgName>
								<orgName type="department" key="dep2">Dubai Health Authority</orgName>
								<orgName type="institution">)</orgName>
								<address>
									<settlement>Dubai</settlement>
									<country key="AE">United Arab Emirates</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff4">
								<note type="raw_affiliation">H Swidown MD) ; Eternal Heart Care Centre &amp; Research Institute , Mount Sinai New York Affiliate , Jaipur , India (R Gupta MD) ;</note>
								<orgName type="department">MD)</orgName>
								<orgName type="institution" key="instit1">H Swidown MD)</orgName>
								<orgName type="institution" key="instit2">Eternal Heart Care Centre &amp; Research Institute</orgName>
								<orgName type="institution" key="instit3">Mount Sinai New York Affiliate</orgName>
								<address>
									<settlement>Jaipur</settlement>
									<region>R Gupta</region>
									<country key="IN">India</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff5">
								<note type="raw_affiliation">Isfahan Cardiovascular Research Center , Cardiovascular Research Institute , Isfahan University of Medical Sciences , Isfahan , Iran (</note>
								<orgName type="department" key="dep1">Isfahan Cardiovascular Research Center</orgName>
								<orgName type="department" key="dep2">Cardiovascular Research Institute</orgName>
								<orgName type="institution">Isfahan University of Medical Sciences</orgName>
								<address>
									<settlement>Isfahan</settlement>
									<country key="IR">Iran</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff6">
								<note type="raw_affiliation">N Mohammadifard PhD) ; FOSCAL , Medical School Universidad de Santander , Bucaramanga , Colombia</note>
								<orgName type="department" key="dep1">N Mohammadifard PhD)</orgName>
								<orgName type="department" key="dep2">FOSCAL</orgName>
								<orgName type="department" key="dep3">Medical School</orgName>
								<orgName type="institution">Universidad de Santander</orgName>
								<address>
									<settlement>Bucaramanga</settlement>
									<country key="CO">Colombia</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff7">
								<note type="raw_affiliation">Department of Internal Medicine , Faculty of Medicine , Istanbul Medeniyet University , Istanbul , Turkey</note>
								<orgName type="department" key="dep1">Department of Internal Medicine</orgName>
								<orgName type="department" key="dep2">Faculty of Medicine</orgName>
								<orgName type="institution">Istanbul Medeniyet University</orgName>
								<address>
									<settlement>Istanbul</settlement>
									<country key="TR">Turkey</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff8">
								<note type="raw_affiliation">Department of Social Medicine , Medical University of Wroclaw , Wroclaw , Poland (</note>
								<orgName type="department">Department of Social Medicine</orgName>
								<orgName type="institution">Medical University of Wroclaw</orgName>
								<address>
									<settlement>Wroclaw</settlement>
									<country key="PL">Poland</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff9">
								<note type="raw_affiliation">K Zatonska PhD) ; Universidad de La Frontera , Temuco , Chile (P Seron</note>
								<orgName type="department">K Zatonska PhD)</orgName>
								<orgName type="institution">Universidad de La Frontera</orgName>
								<address>
									<settlement>Temuco</settlement>
									<country>Chile (P Seron</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff11">
								<note type="raw_affiliation">Avezum MD) ; and Institut universitaire de cardiologie et de pneumologie de Québec , Québec City , QC , Canada</note>
								<orgName type="department">Avezum MD)</orgName>
								<orgName type="institution">Institut universitaire de cardiologie et de pneumologie de Québec</orgName>
								<address>
									<settlement>Québec City</settlement>
									<region>QC</region>
									<country key="CA">Canada</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff12">
								<note type="raw_affiliation">Healthy Heart Program , St Paul&apos;s Hospital , Vancouver , BC , Canada , V6Z 1Y6</note>
								<orgName type="department">Healthy Heart Program</orgName>
								<orgName type="institution">St Paul&apos;s Hospital</orgName>
								<address>
									<postCode>V6Z 1Y6</postCode>
									<settlement>Vancouver</settlement>
									<region>BC</region>
									<country key="CA">Canada</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main" xml:id="_aVynQdw">The effect of physical activity on mortality and cardiovascular disease in 130 000 people from 17 high-income, middle-income, and low-income countries: the PURE study</title>
					</analytic>
					<monogr>
						<imprint>
							<date/>
						</imprint>
					</monogr>
					<idno type="MD5">004B620087C147037B9C2D899B54F710</idno>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.8.2" ident="GROBID" when="2025-08-31T07:48+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<label type="revision">a91ee48</label>
					<label type="parameters">startPage=-1, endPage=-1, consolidateCitations=2, consolidateHeader=2, consolidateFunders=1, includeRawAffiliations=true, includeRawCitations=true, includeRawCopyrights=true, generateTeiIds=true, generateTeiCoordinates=[all], sentenceSegmentation=true, flavor=null</label>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0" xml:id="_38uP6hS"><p xml:id="_4dbgyTu"><s xml:id="_KGM76Pw">Background Physical activity has a protective effect against cardiovascular disease (CVD) in high-income countries, where physical activity is mainly recreational, but it is not known if this is also observed in lower-income countries, where physical activity is mainly non-recreational.</s><s xml:id="_KFnkXsQ">We examined whether different amounts and types of physical activity are associated with lower mortality and CVD in countries at different economic levels.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_rYQx63f">Methods</head><p xml:id="_yrwVdMs"><s xml:id="_QqbzRYY">In this prospective cohort study, we recruited participants from 17 countries (Canada, Sweden, United Arab Emirates, Argentina, Brazil, Chile, Poland, Turkey, Malaysia, South Africa, China, Colombia, Iran, Bangladesh, India, Pakistan, and Zimbabwe).</s><s xml:id="_hXBXfpy">Within each country, urban and rural areas in and around selected cities and towns were identified to reflect the geographical diversity.</s><s xml:id="_Qh2p2Vj">Within these communities, we invited individuals aged between 35 and 70 years who intended to live at their current address for at least another 4 years.</s><s xml:id="_Wx2wPHB">Total physical activity was assessed using the International Physical Activity Questionnaire (IPQA).</s><s xml:id="_d962tgv">Participants with pre-existing CVD were excluded from the analyses.</s><s xml:id="_uDhwpw3">Mortality and CVD were recorded during a mean of 6•9 years of follow-up.</s><s xml:id="_C5JrV72">Primary clinical outcomes during follow-up were mortality plus major CVD (CVD mortality, incident myocardial infarction, stroke, or heart failure), either as a composite or separately.</s><s xml:id="_VTzcCrD">The effects of physical activity on mortality and CVD were adjusted for sociodemographic factors and other risk factors taking into account household, community, and country clustering.</s><s xml:id="_kns6nxt">Findings Between Jan 1, 2003, and Dec 31, 2010, 168 916 participants were enrolled, of whom 141 945 completed the IPAQ.</s><s xml:id="_qDQFdxr">Analyses were limited to the 130 843 participants without pre-existing CVD.</s><s xml:id="_SN5bvmj">Compared with low physical activity (&lt;600 metabolic equivalents [MET] × minutes per week or &lt;150 minutes per week of moderate intensity physical activity), moderate (600-3000 MET × minutes or 150-750 minutes per week) and high physical activity (&gt;3000 MET × minutes or &gt;750 minutes per week) were associated with graded reduction in mortality (hazard ratio 0•80, 95% CI 0•74-0•87 and 0•65, 0•60-0•71; p&lt;0•0001 for trend), and major CVD (0•86, 0•78-0•93; p&lt;0•001 for trend).</s><s xml:id="_Ums2Ryp">Higher physical activity was associated with lower risk of CVD and mortality in high-income, middle-income, and low-income countries.</s></p><p xml:id="_TmPr7zZ"><s xml:id="_mwjKBAF">The adjusted population attributable fraction for not meeting the physical activity guidelines was 8•0% for mortality and 4•6% for major CVD, and for not meeting high physical activity was 13•0% for mortality and 9•5% for major CVD.</s><s xml:id="_4khAswk">Both recreational and non-recreational physical activity were associated with benefits.</s></p><p xml:id="_d2KRfZm"><s xml:id="_CwdpxS4">Interpretation Higher recreational and non-recreational physical activity was associated with a lower risk of mortality and CVD events in individuals from low-income, middle-income, and high-income countries.</s><s xml:id="_ABP69P8">Increasing physical activity is a simple, widely applicable, low cost global strategy that could reduce deaths and CVD in middle age.</s></p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<facsimile>
		<surface n="1" ulx="0.0" uly="0.0" lrx="595.276" lry="799.37"/>
		<surface n="2" ulx="0.0" uly="0.0" lrx="595.276" lry="799.37"/>
		<surface n="3" ulx="0.0" uly="0.0" lrx="595.276" lry="799.37"/>
		<surface n="4" ulx="0.0" uly="0.0" lrx="595.276" lry="799.37"/>
		<surface n="5" ulx="0.0" uly="0.0" lrx="595.276" lry="799.37"/>
		<surface n="6" ulx="0.0" uly="0.0" lrx="595.276" lry="799.37"/>
		<surface n="7" ulx="0.0" uly="0.0" lrx="595.276" lry="799.37"/>
		<surface n="8" ulx="0.0" uly="0.0" lrx="595.276" lry="799.37"/>
		<surface n="9" ulx="0.0" uly="0.0" lrx="595.276" lry="799.37"/>
		<surface n="10" ulx="0.0" uly="0.0" lrx="595.276" lry="799.37"/>
		<surface n="11" ulx="0.0" uly="0.0" lrx="595.276" lry="799.37"/>
		<surface n="12" ulx="0.0" uly="0.0" lrx="595.276" lry="799.37"/>
	</facsimile>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_5k3UwJH">Introduction</head><p xml:id="_CEtcG4y"><s xml:id="_tbsjAUN">Cardiovascular disease (CVD) is the leading cause of death worldwide 1 and a major economic global burden. <ref type="bibr" target="#b1">2</ref> Despite reductions in CVD mortality in high-income countries, global CVD mortality increased by 41% between 1990 and 2013, largely driven by rises in lowincome and lower-middle-income countries. <ref type="bibr" target="#b2">3</ref></s><s xml:id="_2nCHTp9">Indeed, 70% of global CVD deaths come from low-income and middle-income countries, where it is the commonest cause of death. <ref type="bibr" target="#b3">4,</ref><ref type="bibr" target="#b4">5</ref></s><s xml:id="_A3neuUp">23% of the world's population is estimated to be insufficiently active <ref type="bibr" target="#b5">6</ref> and WHO has recommended a decrease in insufficient physical activity of 10% (of the aforementioned 23%) by 2020. <ref type="bibr" target="#b6">7</ref></s><s xml:id="_XFKanc2">any studies from high-income countries have reported significant inverse associations of physical activity with mortality and CVD morbidity, <ref type="bibr" target="#b7">8</ref> but such data from low-income and middle-income countries are sparse and limited to a few small studies. <ref type="bibr" target="#b8">[9]</ref><ref type="bibr" target="#b9">[10]</ref></s><s xml:id="_VGu9Up4">0]<ref type="bibr" target="#b10">[11]</ref> Moreover, studies of physical activity have focused primarily on recreational physical activity (which is common in high-income countries but less common in poorer countries), <ref type="bibr" target="#b7">8,</ref><ref type="bibr" target="#b10">11</ref> with less evidence on the benefits of other forms of physical activity such as during transportation, <ref type="bibr" target="#b11">12</ref> housework, and occupational physical activity. <ref type="bibr" target="#b12">13</ref></s><s xml:id="_fpCuPpt">n the Prospective Urban Rural Epidemiologic (PURE) study done in 17 countries of various income levels, we examined whether physical activity is associated with lower risk of mortality and CVD in countries at varying economic levels and whether these associations differ by type of physical activity.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_dvuDmEM">Methods</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_ySkhmcC">Study design and participants</head><p xml:id="_9hurxWK"><s xml:id="_mrzbsps">The PURE study includes participants from three highincome countries (Canada, Sweden, United Arab Emirates); seven upper-middle-income countries (Argentina, Brazil, Chile, Poland, Turkey, Malaysia, South Africa); three lowermiddle-income countries (China, Colombia, Iran); and four low-income-countries (Bangladesh, India, Pakistan, Zimbabwe). <ref type="bibr" target="#b13">14</ref></s><s xml:id="_FDAd3tD">Country economic level was based on World Bank classifications in 2006.</s><s xml:id="_uVukzd5">The choice and number of countries selected in PURE reflects a balance between involving many countries at different economic levels with substantial heterogeneity in social and economic circumstances versus the feasibility of centres to successfully achieve long-term follow-up.</s></p><p xml:id="_9SsdBr7"><s xml:id="_w7jnDsv">Within each country, urban and rural areas in and around selected cities and towns were identified to reflect the geographical diversity of the countries.</s><s xml:id="_MJMG2WS">Communities were defined based on the geographical clustering of common characteristics (sharing culture [as people of a similar culture reside in close geographical proximity]; socioeconomic status; and use of amenities, goods, and services) such as through a set of contiguous postal code areas or group of streets or a small village.</s><s xml:id="_9FwTrxu">The number of communities selected in each country varied.</s><s xml:id="_24hfKme">In some countries (eg, India, China, Canada, and Colombia), communities from several states and provinces were included to capture diversity, socioeconomic status, culture, and environments.</s><s xml:id="_K8hsAFS">In other countries (eg, Iran, Poland, Sweden, and Zimbabwe), fewer communities were selected.</s><s xml:id="_UrJQMtz">This strategy facilitated recruitment of individuals from different economic, cultural, and geographical settings (rural and urban) around the globe.</s></p><p xml:id="_TsK8jdd"><s xml:id="_NCt3V4p">Within each defined community, households were approached and individuals aged 35-70 years who intended to live at their current address for at least another 4 years were invited to participate in the study.</s><s xml:id="_2TDDpZG">The method of approaching households differed between countries based on feasibility but was consistent across sites within each country.</s><s xml:id="_JwSFVVN">For example, in rural areas of India and China, a community announcement was made to the village through contact of a community leader, followed by inperson door-to-door visits of all households.</s><s xml:id="_MhCRNSn">In Canada, initial contact was by mail followed by telephone invitations to attend a central clinic.</s><s xml:id="_TCGYvjX">For each household at least three attempts at contact were made.</s><s xml:id="_YZDP66u">All eligible residents of the household were invited and those who provided informed consent were recruited.</s><s xml:id="_zJJKsZv">Household participation rate was 86%.</s><s xml:id="_HNt2nG8">Recruitment started in a vanguard phase in Karnataka, India in January, 2003; however most communities recruited between January, 2005, and</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_u6Ha3pj">Research in context</head><p xml:id="_5htCv8Y"><s xml:id="_pQ2mTzf">Evidence before this study We searched the MEDLINE database for articles regarding the role of physical activity and exercise on mortality and cardiovascular disease across countries at various economic levels.</s><s xml:id="_AXF2NdX">We used the terms "physical activity", "exercise", "mortality", "cardiovascular disease" in English but without date restrictions.</s><s xml:id="_s4tSWQ9">We screened papers by title and abstract to identify full-text papers that were relevant to the study aims.</s><s xml:id="_mbX6fnx">We also screened citation lists from these full-text papers to identify other relevant research.</s><s xml:id="_Gsae4GR">The papers cited in this report were selected to be representative of the existing evidence base, and are not an exhaustive list of relevant research.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_gtKzK5X">Added value of this study</head><p xml:id="_2dpMp8g"><s xml:id="_Jh4PjqN">Studies investigating the role of physical activity in preventing death from cardiovascular disease have been primarily from high-income countries, and focused on recreational or leisure time physical activity.</s><s xml:id="_j3AxfaP">In low-income and middle-income countries, physical activity is predominantly from non-recreational activities such as transportation, occupation, and housework, and therefore findings in high-income countries might not apply to other countries.</s><s xml:id="_fJfCUsC">A few studies have reported on the role of physical activity in low-income and middle-income countries, but these were cross-sectional or used inconsistent methods and are therefore not robust.</s><s xml:id="_ksghrUF">Our investigation looks at the relationship between recreational and non-recreational physical activity and incident events in countries from all regions of the world.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_A2773eu">Implications of all the available evidence</head><p xml:id="_jBrjexd"><s xml:id="_cREaAnk">Physical activity is associated with reduced risk of mortality and incident cardiovascular disease in all regions of the world.</s><s xml:id="_cSCPbHd">The greatest reductions occurred at the lowest and continued to be present at very high levels of physical activity with no indication of a ceiling effect.</s><s xml:id="_sjqnCeh">In addition, both recreational and non-recreational physical activity were associated with lower risks.</s><s xml:id="_VUD9u2c">Physical activity is a low-cost approach to reducing deaths and cardiovascular disease that is applicable globally with potential large impact.</s></p><p xml:id="_84CAQZj"><s xml:id="_ngZZ6eJ">December, 2010 (appendix).</s><s xml:id="_CVywQFS">The study was approved by local institutional research ethics boards.</s></p><p xml:id="_ZFvpDhC"><s xml:id="_c8YYVU6">Sociodemographic factors, medical history, lifestyle behaviours, and risk factors were recorded using standardised measures and procedures. <ref type="bibr" target="#b10">11</ref></s><s xml:id="_xhCSAy6">1-week total physical activity was assessed using the long-form International Physical Activity Questionnaire (IPAQ) <ref type="bibr" target="#b14">15</ref> and calculated as a total of occupation, transportation, house work, and recreational activity reported in metabolic equivalents (MET) × minutes per week.</s><s xml:id="_bnVaTet">Physical activity was also reported in minutes per week of moderate intensity physical activity using the equation where minutes reported in each physical activity domain on the IPAQ by the participant are weighted relative to moderate intensity physical activity:</s></p><p xml:id="_9AQzMNQ"><s xml:id="_wjJB7fh">Total physical activity was categorised as low (&lt;600 MET × minutes per week), moderate (600-3000 MET × minutes per week), and high (&gt;3000 MET × minutes per week) physical activity, corresponding to less than 150 minutes per week, 150-750 minutes per week, and more than 750 minutes per week of moderate intensity physical activity.</s><s xml:id="_w4Bu7XJ">Physical activity was also dichotomised as meeting or not meeting current physical activity guidelines (≥600 MET × minutes per week as per the IPAQ <ref type="bibr" target="#b14">15</ref> or physical activity ≥150 minutes per week of moderate intensity physical activity as per WHO <ref type="bibr" target="#b15">16</ref> ) with periods of less than 10 minutes of physical activity not included as per the IPAQ guidelines. <ref type="bibr" target="#b14">15,</ref><ref type="bibr" target="#b15">16</ref></s><s xml:id="_sqDFP9e">We further categorised the high physical activity category into lower-high physical activity and an upper-high physical activity by the median value of the high physical activity category of 6453 MET × minutes per week to investigate whether the effect of very high physical activity was graded.</s><s xml:id="_QprdtVx">Physical activity was categorised into recreational physical activity and non-recreational physical activity (occupational, transportation, and housework).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_55jHrDY">Outcomes</head><p xml:id="_5CuBPqr"><s xml:id="_UsmXNaB">Primary clinical outcomes during follow-up were mortality plus major CVD (CVD mortality plus incident myocardial infarction, stroke, or heart failure), either as a composite or separately (appendix).</s><s xml:id="_qpA3h5V">In most low-income and middleincome countries there was no central system of death or event registration.</s><s xml:id="_SV7YSC8">We therefore obtained information on history of illness and medically certified cause of death where available, and recorded best available information from close family or friends to arrive at a probable diagnosis or cause of death.</s><s xml:id="_ap56tRn">Death certificates (available in 100% of deaths), medical records (percentage of availability of medical records for the following conditions: myocardial infarc tion 49•4%, stroke 80•8%, and heart failure 76•2%), household interviews, and other sources of information were used.</s><s xml:id="_Excm4fB">We also used verbal autopsies to ascertain cause of death in addition to medical records that were reviewed by a health prof essional. <ref type="bibr" target="#b16">17</ref></s><s xml:id="_GQemavN">To ensure a standard approach and accuracy for classification of events across all countries and over time, a selection of cases from each country annually was adjudicated both locally and also by the adjudication chair, and further training was provided if necessary.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_yyrdNZE">Statistical analyses</head><p xml:id="_fYVWCmn"><s xml:id="_KkhKfpM">Sample size was not predetermined; we aimed to use as many participants as possible with no maximum limit.</s><s xml:id="_t8xVqME">The primary analyses were done excluding participants who reported having CVD at baseline.</s><s xml:id="_wch9Gwa">Baseline characteristics were described for the entire cohort and stratified by low, moderate, and high total physical activity.</s><s xml:id="_muJ3pyQ">Total and domain-specific physical activity values were not normally distributed and are presented as median and IQR. <ref type="bibr">18</ref></s><s xml:id="_5w9JJuJ">The Kruskal-Wallis test and Jonckheere-Terpstra test <ref type="bibr" target="#b17">19,</ref><ref type="bibr" target="#b18">20</ref> were used to test the heterogeneity and trend across the four country income levels (high-income countries, uppermiddle-income countries, lower-middle-income countries, or low-income countries), respectively.</s><s xml:id="_2TaVAF8">For the two categorical physical activity variables: total physical activity and whether meeting physical activity guideline, we calculated frequencies and compared their difference and trend across the country income levels using the χ² test and Cochran-Armitage test, <ref type="bibr" target="#b19">21,</ref><ref type="bibr" target="#b20">22</ref> as appropriate.</s></p><p xml:id="_nmtrEHQ"><s xml:id="_w2sNYYb">Age-sex-standardised incidence rates for all outcomes were calculated for total physical activity and whether meeting physical activity guidelines. <ref type="bibr" target="#b21">23</ref></s><s xml:id="_nm7JRwP">To examine the association between physical activity variables and outcomes, we used the marginal Cox proportional hazard model. <ref type="bibr" target="#b22">24,</ref><ref type="bibr" target="#b23">25</ref></s><s xml:id="_6qvn5Gb">Models were adjusted for age, sex, education, country income level, residency (urban vs rural), family history of CVD, and smoking status (current or ever smoker vs never smoker; cigarette, cigar, and pipe smoking) taking into account three levels of clustering.</s><s xml:id="_gsEaaas">We did further analyses using wealth index and household income (in separate models) in place of education but these did not change the results.</s><s xml:id="_Kbx8TG6">We further adjusted for body-mass index (BMI).</s></p><p xml:id="_2zZTS9q"><s xml:id="_3Xs2ZSG">Adjusted population attributable fractions that were related to not meeting physical activity guidelines and not achieving high physical activity were calculated to quantify the benefit of physical activity, using the method developed by Chen and colleagues. <ref type="bibr" target="#b24">26</ref></s><s xml:id="_TsaQ9XG">To minimise the potential for reverse causation, we did sensitivity analyses by excluding participants who had CVD events in the first 2 years of follow-up.</s><s xml:id="_pBcyshm">Additional analyses were also done including PURE participants who had CVD at baseline (n=141 945), which yielded similar results.</s><s xml:id="_sngANyb">We estimated the effect of total physical activity on the outcomes by country income level; sex; age (&lt;50 or ≥50 years); BMI (&lt;25 kg/m² or ≥25 kg/m²); waist-to-hip ratio (above 0•85 for women and girls, 0•90 for men and boys); and smoking, hypertension, and diabetes.</s></p><p xml:id="_QWFJ5UT"><s xml:id="_2KvdcpT">See Online for appendix Min per week = 0•825 × walking min + 1 × moderate min + 1•375 × garden min + 1•5 × cycling min + 2 × vigorous min Overall (n=130 843) Low physical activity* (n=23 631) Moderate physical activity † (n=49 348) High physical activity ‡ (n=57 864) Age (years) 50•2 (9•7) 51•0 (10•1) 50•5 (9•7) 49•7 (9•5) Male 54 621 (41•7%) 11 080 (46•9%) 18 224 (36•9%) 25 317 (43•8%) Urban resident 69 993 (53•5%) 12 983 (54•9%) 28 525 (57•8%) 28 485 (49•2%) Country income level High 13 546 (10•4%) 1435 (6•1%) 4991 (10•1%) 7120 (12•3%) Upper middle 34 625 (26•5%) 7479 (31•6%) 11 922 (24•2%) 15 224 (26•3%) Lower middle 53 841 (41•1%) 8620 (36•5%) 22 648 (45•9%) 22 573 (39•0%) Low 28 831 (22•0%) 6097 (25•8%) 9787 (19•8%) 12 898 (22•4%) Education None, primary, or unknown 54 635 (41•9%) 10 642 (45•2%) 19 085 (38•8%) 24 908 (43•1%) Secondary 50 500 (38•7%) 9035 (38•3%) 19 746 (40•1%) 21 719 (37•6%) Trade, college, or university 25 396 (19•5%) 3885 (16•5%) 10 412 (21•1%) 11 099 (19•2%) Family history of heart disease or stroke 36 812 (31•3%) 4911 (23•5%) 13 605 (30•5%) 18 296 (35•0%) Hypertension 47 752 (39•0%) 9053 (42•6%) 18 364 (39•7%) 20 335 (36•9%) Diabetes 12 740 (9•7%) 2898 (12•3%) 5102 (10•3%) 4740 (8•2%) Smoker (current and former) 40 955 (31•5%) 7093 (30•3%) 13 695 (28•0%) 20 167 (35•0%) Alternate Healthy Eating Index score 35•1 (8•0) 34•9 (7•6) 35•5 (7•9) 34•8 (8•3) Body-mass index (kg/m²) 25•7 (5•1) 25•9 (5•4) 25•9 (5•0) 25•4 (5•1) Data are mean (SD) or n (%).</s><s xml:id="_F5EEmAu">MET=metabolic equivalents.</s><s xml:id="_psjMMYN">*Low physical activity=&lt;600 MET × min per week and &lt;150 min per week of moderate intensity physical activity.</s><s xml:id="_5rfJQRh">†Moderate physical activity=600-3000 MET × min per week and 150-750 min per week of moderate intensity physical activity.</s><s xml:id="_bdaaTPG">‡High physical activity=&gt;3000 MET × min per week and &gt;750 min per week of moderate intensity physical activity.</s></p><p xml:id="_zVTbs9Y"><s xml:id="_ye7MtsT">Table 1: Participant characteristics stratified by total physical activity High-income countries (n=13 546) Upper-middleincome countries (n=34 625) Lower-middleincome countries (n=53 841) Low-income countries (n= 28 831) p value (for heterogeneity) p value (for trend) Total physical activity* •• •• •• •• &lt;0•0001 &lt;0•0001 MET × min per week 3227 (1485-6426) 2436 (750-5979) 2340 (960-5177) 2520 (721-6442) •• •• Min per week 807 (371-1607) 609 (188-1495) 585 (240-1294) 630 (180-1611)</s></p><formula xml:id="formula_0">•• •• Recreational physical activity* •• •• •• •• &lt;0•0001 &lt;0•0001 MET × min per week 518 ( 50-1386) 0 ( 0-320) 99 ( 0-693) 0 ( 0-0) •• •• Min per week 130 ( 12-347) 0 ( 0-80) 25 ( 0-173) 0 ( 0-0) •• •• Non-recreational physical activity* •• •• •• •• &lt;0•0001 0.7762 MET ×</formula><p xml:id="_P58xkG6"><s xml:id="_s4rgPSg">min per week 2115 (806-4980) 1983 (578-5400) 1748 (693-4186) 2297 (594-6222) •• •• Min per week 529 (202-1245) 496 (144-1350) 437 (173-1047) 574 (149-1556) •• •• Low physical activity † 1435 (10•6%) 7479 (21•6%) 8620 (16•0%) 6097 (21•1%) &lt;0•0001 •• Moderate physical activity ‡ 4991 (36•8%) 11 922 (34•4%) 22 648 (42•1%) 9787 (33•9%) •• •• High physical activity § 7120 (52•6%) 15 224 (44•0%) 22 573 (41•9%) 12 947 (44•9%) •• •• Meeting physical activity guidelines ¶ 12 111 (89•4%) 27 146 (78•4%) 45 221 (84•0%) 22 734 (78•9%) &lt;0•0001 &lt;0•0001 Data are median (IQR) or n (%).</s><s xml:id="_aEpQcYt">p value for heterogeneity was calculated by χ2 test for categorical variable and Kruskal-Wallis for continuous variable.</s><s xml:id="_PCP9kYT">p value for trend was calculated by Cochran-Armitage test for categorical variable and Jonckheere-Terpstra test for continuous variable. 15,16</s><s xml:id="_N5UFjAF">MET=metabolic equivalents.</s><s xml:id="_P6jz8wM">*Moderate intensity physical activity.</s><s xml:id="_TBB85nR">†Low physical activity &lt;600 MET × min per week and &lt;150 min per week of moderate intensity physical activity.</s><s xml:id="_teMVxUw">‡Moderate physical activity 600-3000 MET × min per week and 150-750 min per week of moderate intensity physical activity.</s><s xml:id="_gmbQH2t">§High physical activity &gt;3000 MET × min per week and &gt;750 min per week of moderate intensity physical activity.</s><s xml:id="_5HT2jwV">¶Meeting physical activity guidelines ≥600 MET × min per week and ≥150 min per week of moderate intensity physical activity.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_bPgZtw6">Table 2: Physical activity by country income level</head><p xml:id="_PWqRe6d"><s xml:id="_jwMavW8">To assess and compare the effect of recreational physical activity versus non-recreation physical activity, we fitted the adjusted marginal Cox model with restricted cubic spline with four knots at the 5th, 35th, 65th, and 95th percentiles for overall and non-recreational physi cal activity. <ref type="bibr" target="#b25">27</ref></s><s xml:id="_nfzUgyA">Because 55% of participants had no recreational physical activity, we chose 50th, 65th, 80th, and 95th percentile as the knots.</s><s xml:id="_tQBmvs2">We also examined whether the association between physical activity and outcomes varied by country income and by type of physical activity (total, recreational, or non-recreational) using tests of interaction to compare the effects between high-income countries and upper-middle-income countries versus lower-middle-income countries and low-income coun tries.</s><s xml:id="_FnqAjRv">All analyses were done using SAS 9.4, for UNIX operating system (SAS Institute, Cary, USA) and R software, version 3.2.5, for Windows system.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_2NbWJ7r">Role of the funding source</head><p xml:id="_haZFceg"><s xml:id="_hZ3k5gP">The funders and sponsors had no role in the design and conduct of the study; in the collection, analysis, and interpretation of the data; in the preparation, review, or approval of the manuscript; or in the decision to submit the manuscript for publication.</s><s xml:id="_tSQczZJ">The corresponding author had full access to all the data in the study and had final responsibility for the decision to submit for publication.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_7vDGf6E">Results</head><p xml:id="_YpF9dKq"><s xml:id="_MqUUZBt">Between Jan 1, 2003, and Dec 31, 2010, we enrolled 168 916 participants, of whom 141 945 completed the IPAQ.</s><s xml:id="_xeZu4cX">Analyses were limited to the 130 843 participants without pre-existing CVD.</s><s xml:id="_DaPZ49t">Table <ref type="table">1</ref> presents participant charac teristics stratified by low, moderate, and high physical activity.</s><s xml:id="_vR39feX">Participant characteristics were not materially different in most features across the three groups with the exception of a lower proportion of males in the moderate physical activity group compared with the others and a greater proportion of family history of CVD in the high physical activity group.</s><s xml:id="_ZbVs3kq">The prevalence of hypertension and diabetes were lower with higher physical activity.</s><s xml:id="_6kGSjhq">There was no association between diet score or BMI and physical activity.</s></p><p xml:id="_DyNQFZa"><s xml:id="_4SXys64">Table <ref type="table">2</ref> presents physical activity by country income level in both MET × minutes per week and minutes per week of moderate intensity physical activity.</s><s xml:id="_xgjmm4C">There was a trend towards lower total physical activity and recreational physical activity from high-income countries to low-income countries (p&lt;0•0001 for both), but not for non-recreational physical activity.</s><s xml:id="_NK6vsPV">Most participants met the physical activity guidelines, but fewer than half of the participants reached high physical activity.</s></p><p xml:id="_BRWA59R"><s xml:id="_QMjZ3w4">During the mean follow-up of 6</s></p><p xml:id="_assDy3w"><s xml:id="_twGCZ4m">•9 years (SD 3•0) there were 5334 deaths in total (1294 deaths from CVD and 4040 deaths from non-CVD causes), 1987 individuals with incident myocardial infarction, 2086 individuals with incident stroke, and 386 individuals with new heart failure (appendix).</s><s xml:id="_Z6Uhtvw">When stratified by physical Mortality plus major CVD* Mortality Major CVD CVD mortality Non-CVD mortality Myocardial infarction Stroke Heart failure Events Rate Events Rate Events Rate Events Rate Events Rate Events Rate Events Rate Events Rate Low physical activity † (n=23 549) 1941 9•46 (8•99-9•94) 1396 6•37 (5•99-6•76) 1000 5•13 (4•78-5•48) 377 1•75 (1•55-1•94) 1019 4•63 (4•30-4•96) 496 2•64 (2•39-2•89) 427 2•09 (1•87-2•31) 84 0•42 (0•32-0•52) Moderate physical activity ‡ (n=49 245)</s></p><p xml:id="_6PNnacK"><s xml:id="_rVMR7ap">3002 7•14 (6•86-7•43) 1881 4•25 (4•04-4•47) 1682 4•13 (3•91-4•34) 480 1•12 (1•01-1•23) 1401 3•13 (2•95-3•32) 730 1•86 (1•71-2•00) 820 1•93 (1•79-2•08) 144 0•34 (0•27-0•40) High physical activity § (n=57 725) 3233 6•60 (6•36-6•84) 2057 4•11 (3•92-4•30) 1718 3•53 (3•35-3•70) 437 0•87 (0•78-0•96) 1620 3•24 (3•07-3•40) 761 1•58 (1•47-1•70) 839 1•68 (1•56-1•80) 158 0•30 (0•25-0•36)</s></p><p xml:id="_UEgtqAv"><s xml:id="_z6J4DJH">p for trend</s></p><formula xml:id="formula_1">•• p&lt;0•0001 •• p&lt;0•0001 •• p&lt;0•0001 •• p&lt;0•0001 •• p&lt;0•0001 •• p&lt;0•0001 •• p=0•0010</formula><p xml:id="_SunzXQ3"><s xml:id="_R7UfQJT">•• p=0•0997 Not meeting recommendations (n=23 549) 1941 9•46 (8•99-9•94) 1396 6•37 (5•99-6•76) 1000 5•13 (4•78-5•48) 377 1•75 (1•55-1•94) 1019 4•63 (4•30-4•96) 496 2•64 (2•39-2•89) 427 2•09 (1•87-2•31) 84 0•42 (0•32-0•52) Meeting recommendations (n=106 970) 6235 6•86 (6•68-7•05) 3938 4•19 (4•05-4•33) 3400 3•80 (3•66-3•94) 917 0•98 (0•92-1•05) 3021 3•21 (3•08-3•33) 1491 1•71 (1•62-1•81) 1659 1•79 (1•70-1•88) 302 0•32 (0•28-0•35) p for trend .. p&lt;0•0001</s></p><formula xml:id="formula_2">•• p&lt;0•0001 •• p&lt;0•0001 •• p&lt;0•0001 •• p&lt;0•0001 •• p&lt;0•0001 •• p=0•0088</formula><p xml:id="_ECem7Ym"><s xml:id="_2jRvfVp">•• p=0•0376 Event rates are standardised for age and sex.</s><s xml:id="_N5HgB4N">Data are n, or n per 1000 person-years (95% CI).</s><s xml:id="_WckY6Qz">A maximum of one event per participant is tabulated for each outcome.</s><s xml:id="_g5a3s2g">CVD=cardiovascular disease.</s><s xml:id="_p2X36sZ">MET=metabolic equivalents.</s><s xml:id="_cYCdJ49">*Major CVD=CVD mortality plus incident myocardial infarction, stroke, or heart failure.</s><s xml:id="_NNMqjsU">†Low physical activity=&lt;600 MET × min per week and &lt;150 min per week of moderate intensity physical activity.</s><s xml:id="_uaq4ex4">‡Moderate physical activity=600-3000 MET × min per week and 150-750 min per week of moderate intensity physical activity.</s><s xml:id="_hQJUdn3">§High physical activity=&gt;3000 MET × min per week and &gt;750 min per week of moderate intensity physical activity.</s></p><p xml:id="_s6vZX9v"><s xml:id="_gNP6fMs">Table 3: Summary of fatal and non-fatal events by physical activity activity, there was a graded reduction in age and sex adjusted event rates for all outcomes except heart failure from low to moderate to high physical activity (table 3).</s><s xml:id="_NkbCC6E">Participants meeting the guidelines for physical activity had lower age and sex adjusted rates of all outcomes (table 3).</s></p><p xml:id="_5V9TJdQ"><s xml:id="_XsZSQVM">Participating in physical activity at or above the physical activity guidelines was associated with significantly lower rates of outcomes compared with those participants not meeting the physical activity guidelines (≥600 MET × minutes per week as per IPAQ, <ref type="bibr" target="#b14">15</ref> or physical activity ≥150 minutes per week of moderate intensity physical activity as per WHO <ref type="bibr" target="#b15">16</ref> ).</s><s xml:id="_35vT6Re">In fully adjusted models, meeting physical activity guidelines was associated with hazard ratios (HRs) of 0•78 for mortality plus major CVD (95% CI 0•74-0•83), 0•72 (0•67-0•77) for mortality, and 0•80 (0•74-0•86) for major CVD (p&lt;0•0001 for all).</s></p><p xml:id="_stjCYMT"><s xml:id="_Ta7wYSS">In fully adjusted models, moderate and high physical activity were associated with lower HRs for mortality plus major CVD (p&lt;0•0001 for trend), mortality (p&lt;0•0001 for trend), and major CVD (p=0•0005 trend) compared with those with low total physical activity (figure <ref type="figure" target="#fig_1">1</ref>).</s><s xml:id="_fyaMAHA">When adjusted for either wealth index or household income Hazard ratio (95% CI) All-cause mortality and major CVD All-cause mortality Major CVD 0•85 (0•80-0•91) p&lt;0•0001 p&lt;0•0001 0•85 (0•80-0•90) p&lt;0•0001 0•73 (0•68-0•77) p&lt;0•0001 0•80 (0•74-0•87) p&lt;0•0001 p&lt;0•0001 0•81 (0•75-0•87) p&lt;0•0001 0•65 (0•60-0•71) p&lt;0•0001 0•86 (0•78-0•93) p=0•0004 p=0•0004 0•88 (0•82-0•94) p=0•0005 0•75 (0•69-0•82) p&lt;0•0001 0•8 0•6 0•4 1•0 1•2 Favours lower physical activity Favours higher physical activity Moderate physical activity vs low physical activity High physical activity vs low physical activity High physical activity vs moderate physical activity HR (95% CI) Total Event Description Female Male Age &lt;50 years Age ≥50 years BMI &lt;25 BMI ≥25 Normal WHR High WHR Non-smoker Smoker No hypertension Hypertension No diabetes Diabetes Below diet score median Above diet score median</s></p><p xml:id="_XMA7A6j"><s xml:id="_BngtSMF">Total 68 130 47 953 55 221 60 862 50 483 58 929 54 268 55 318 79 336 36 747 64 757 44 375 105 103 10 980 52 997 55 527 116 083 1716 2234 803 3147 1935 1646 1510 2126 2137 1813 1511 2081 3153 797 2011 1646 3950 High PA vs low PA Moderate PA vs low PA High PA vs low PA Moderate PA vs low PA High PA vs low PA Moderate PA vs low PA High PA vs low PA Moderate PA vs low PA High PA vs low PA Moderate PA vs low PA High PA vs low PA Moderate PA vs low PA High PA vs low PA Moderate PA vs low PA High PA vs low PA Moderate PA vs low PA High PA vs low PA Moderate PA vs low PA High PA vs low PA Moderate PA vs low PA High PA vs low PA Moderate PA vs low PA High PA vs low PA Moderate PA vs low PA High PA vs low PA Moderate PA vs low PA High PA vs low PA Moderate PA vs low PA High PA vs low PA Moderate PA vs low PA High PA vs low PA Moderate PA vs low PA High PA vs low PA Moderate PA vs low PA</s></p><formula xml:id="formula_3">0•58 (0•51-0•65) 0•74 (0•66-0•84) 0•71 (0•64-0•79) 0•85 (0•76-0•95) 0•60 (0•50-0•72) 0•75 (0•62-0•90) 0•67 (0•61-0•73) 0•82 (0•75-0•89) 0•66 (0•58-0•74) 0•85 (0•76-0•96) 0•73 (0•64-0•83) 0•83 (0•73-0•95) 0•67 (0•58-0•76) 0•86 (0•75-0•99) 0•69 (0•62-0•77) 0•81 (0•72-0•90) 0•61 (0•54-0•68) 0•77 (0•70-0•86) 0•71 (0•63-0•80) 0•85 (0•75-0•96) 0•68 (0•60-0•78) 0•80 (0•70-0•92) 0•68 (0•61-0•76) 0•85 (0•76-0•95) 0•66 (0•61-0•73) 0•81 (0•74-0•89) 0•68 (0•57-0•82) 0•80 (0•67-0•95) 0•67 (0•59-0•75) 0•85 (0•76-0•95) 0•65 (0•57-0•74) 0•79 (0•70-0•90) 0•65 (0•60-0•71) 0•80 (0•74-0•87) 0•8 0•5 0•4 1•0 1•1 0•6 0•9 0•7</formula></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_NzsGX7f">Favours physical activity</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_YbFFJSG">Figure 2: Hazard ratios and 95% CI of total physical activity for mortality</head><p xml:id="_NRZV2Eb"><s xml:id="_pyGvbBd">Adjusted for age, sex, education, country income level, urban or rural residency, family history of cardiovascular disease, and smoking status taking into account household, community, and country clustering.</s><s xml:id="_jteydZj">Based on data for 115 436 participants with complete data.</s><s xml:id="_974rVG3">Low physical activity (&lt;600 MET × min per week) is the reference group.</s><s xml:id="_KaHeKMa">Moderate physical activity=600-3000 MET × min per week.</s><s xml:id="_y3YKdTW">High physical activity=&gt;3000 MET × min per week.</s><s xml:id="_cdCJPAn">PA=physical activity.</s><s xml:id="_k6V8mQN">HR=hazard ratio.</s><s xml:id="_ha23DSD">MET=metabolic equivalents.</s><s xml:id="_JJSXEK6">BMI=body-mass index.</s><s xml:id="_jZYKUvj">WHR=waist-to-hip ratio (high WHR was defined as above 0•85 for women and girls and above 0•9 for men and boys).</s></p><p xml:id="_qDddzyg"><s xml:id="_2fzV9Qj">in place of education, HRs did not change (appendix).</s><s xml:id="_3DWUBk2">High physical activity was associated with a lower HR than was moderate physical activity for all outcomes.</s><s xml:id="_umBKvVt">Dichotomising high physical activity above or below the median value in this group of 6453 MET × minutes per week did not show further reductions in risk (appendix).</s><s xml:id="_WFDzmpZ">Higher physical activity was also associated with lower HRs in CVD mortality, non-CVD mortality, and myocardial infarction (appendix).</s><s xml:id="_TdPsFPm">With further adjustment for BMI, the HRs were slightly attenuated but remained significant (appendix).</s><s xml:id="_TG8uG92">Excluding participants who had a CVD event within the first 2 years of follow-up (to account for potential reverse causality if sick individuals were less active), the results were consistent for all outcomes (appendix).</s></p><p xml:id="_T8u2guX"><s xml:id="_BCzp9B6">Survival curves for low, moderate, and high physical activity for our three primary outcomes of mortality plus major CVD, mortality, and major CVD indicated a lower risk as physical activity increased (p&lt;0•0001; appendix).</s></p><p xml:id="_v4YVynw"><s xml:id="_hbSshmG">The 5-year adjusted population attributable fraction of not meeting the physical activity guidelines was 5•3% for mortality plus major CVD, 8•0% for mortality, and 4•6% for major CVD (appendix).</s><s xml:id="_htFtYFP">These values were higher (10•3% for mortality plus major CVD, 13•0% for mortality, and 9•5% for major CVD) in participants who did not achieve high physical activity (appendix).</s></p><p xml:id="_z9uzyyR"><s xml:id="_5ab9yxb">Increasing physical activity was associated with lower risk of mortality in a range of subgroups (figure <ref type="figure">2</ref>).</s><s xml:id="_u5GYHDX">Compared with low physical activity, moderate and high physical activity were associated with a lower graded risk for mortality regardless of sex, age, and in the presence of risk factors.</s></p><p xml:id="_duxNRp8"><s xml:id="_BDkCqSg">Higher physical activity was associated with significantly lower risk up to approximately 3000 MET × minutes per week (or 750 minutes per week of moderate intensity physical activity) with more modest benefits above that physical activity (p&lt;0•0001; figure <ref type="figure" target="#fig_2">3</ref>).</s><s xml:id="_hk8GCVQ">For recreational physical activity, higher physical activity was associated with significantly lower risk up to approximately 600 MET × minutes per week (or 150 minutes per week of moderate intensity physical activity, p=0•01; as few had physical activity higher than this), and for non-recreational physical activity, higher physical activity was associated with significantly lower risk up to approximately 5000 MET × minutes per week (or 1250 minutes per week 0 600 3000 150 750 1000 2000 3000 0 5000 10 000 15 000 0•5 Hazard ratio Total physical activity, MET × min per week Total physical activity, minutes/week p for total physical activity &lt;0•0001 p for non-linearity &lt;0•0001 0•6 0•7 0•8 0•9 1•0 1•1 A Interval (MET × min per week) Total Number of events Interval (MET × min per week) Total Number of events Interval (MET × min per week) Total Number of events 0-600 21 690 1941 600-3000 46 409 3007 3000-5000 18 781 1028 5000-10 000 20 801 1247 10 000-15 000 8566 507 &gt;15 000 6420 446 0 600 3000 150 750 1000 2000 3000 0 5000 10 000 15 000 0•5 Hazard ratio Recreational physical activity, MET × min per week Recreational physical activity, minutes/week p for recreational physical activity = 0•01 p for non-linearity = 0•01 0•6 0•7 0•8 0•9 1•0 1•1 B 0-600 94 893 6647 600-3000 24 177 1342 &gt;3000 3597 187 0 600 3000 150 750 1000 2000 3000 0 5000 10 000 15 000 0•5 Hazard ratio Non-recreational physical activity, MET × min per week Non-recreational physical activity, minutes/week p for non-recreational physical activity &lt;0•0001 p for non-linearity &lt;0•0001 0•6 0•7 0•8 0•9 1•0 1•1 C 0-600 27 968 2384 600-3000 47 964 2964 3000-5000 15 571 873 5000-10 000 17 547 1077 10 000-15 000 7597 459 &gt;15 000 6020 419</s></p><p xml:id="_FCrsr6w"><s xml:id="_jgf9yc8">of moderate intensity physical activity) with more modest benefits above that level of physical activity (p&lt;0•0001).</s></p><p xml:id="_5rjHn3A"><s xml:id="_MzxkNyB">Higher physical activity was associated with significantly lower risk for mortality plus major CVD in upper-middleincome countries and low-income countries; mortality in upper-middle-income countries, lower-middle-income countries, and low-income countries; and major CVD in upper-middle-income countries and low-income countries (table <ref type="table">4</ref>).</s><s xml:id="_yFUG834">When stratified by country income level (highincome countries and upper-middle-income countries vs lower-middle-income countries and low-income countries) there was a significant interaction between country income level and physical activity for total (p=0•0012) and recreational physical activity (p=0•0063) such that the high-income countries and upper-middle-income countries had a lower risk with increasing physical activity (figure <ref type="figure" target="#fig_3">4</ref>).</s><s xml:id="_YKNpxp5">This was less clear for non-recreational physical activity (p=0•063).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_nypwbbQ">Discussion</head><p xml:id="_nqfHJMc"><s xml:id="_MJTPwp6">In this study involving three high-income countries, seven upper-middle-income countries, three lowermiddle-income countries, and four low-income countries, higher physical activity was associated with a lower risk for mortality and incidence of major CVD.</s><s xml:id="_tDSmNFx">This lower risk was present even at moderate physical activity compared with low physical activity, and was more marked at higher physical activity.</s><s xml:id="_FBpZ47u">The benefit of physical activity was independent of the type of physical activity (recreational or non-recreational), a range of Country income level HIC+UMIC LMIC+LIC 0•5 Hazard ratio (95% CI ) p for interaction=0•0012 ).</s><s xml:id="_CWnz3RN">Hazard ratios (and 95% CI) were adjusted for age, sex, education, country income level, urban or rural residency, family history of CVD, and smoking status taking into account household, community, and country clustering.</s><s xml:id="_Rtc6FYF">Low physical activity (&lt;600 MET × min per week) is the reference group.</s><s xml:id="_QWzgA8G">CVD=cardiovascular disease.</s><s xml:id="_7uDc62a">MET=metabolic equivalents.</s><s xml:id="_AJpxPmH">*CVD mortality plus incident myocardial infarction, stroke, or heart failure.</s><s xml:id="_d8jef3m">†Moderate physical activity=600-3000 MET × min per week and 150-750 min per week of moderate intensity physical activity.</s><s xml:id="_a93G8VQ">‡High physical activity=&gt;3000 MET × min per week and &gt;750 min per week of moderate intensity physical activity.</s></p><formula xml:id="formula_4">0•6 0•7 0•8 0•9 1•0 1•1 1•3 1•2 A 0•5 Hazard ratio (95% CI ) p for interaction=0•0063 0•6 0•7 0•8 0•9 1•0 1•1 1•3 1•2 B Low Moderate</formula><p xml:id="_6ygM3Bd"><s xml:id="_C6ub8AA">Table 4: Summary of risk of mortality and major CVD events stratified by country income level and physical activity</s></p><p xml:id="_bhKXj6f"><s xml:id="_hWzEXrJ">socioeconomic and CVD risk factors, and was similar in various countries with differing income levels.</s></p><p xml:id="_HcvjtER"><s xml:id="_gCwNqMF">In our study participants who reside in predominantly non-high-income countries, meeting the WHO guideline of 150 minutes per week of moderate intensity of physical activity was associated with a 22% lower risk for all-cause mortality plus major CVD, 28% lower risk of mortality, and 20% lower risk of major CVD, resulting in adjusted population attributable fractions of 5•3% for all-cause mortality plus major CVD, 8•0% for mortality, and 4•6% for major CVD.</s><s xml:id="_DQBSu7G">These attributable fractions are similar to those reported by Lee and colleagues: <ref type="bibr" target="#b8">9</ref> 9•4% for mortality and 5•8% for CVD in high-income coun tries.</s><s xml:id="_B7chTy7">We observed a graded effect, such that participants with higher physical activity had a lower risk than those participants engaging in moderate physical activity.</s><s xml:id="_9yBFHAd">For example, compared with people at moderate physical activity, high physical activity conferred an additional reduction in risk of 15% for mortality plus major CVD, 19% for mortality, and 12% for major CVD.</s><s xml:id="_Bg3t9RJ">This benefit plateaued only at very high physical activity (approximately 1250 minutes per week of moderate intensity physical activity).</s><s xml:id="_QAgvg4A">Similar to previous studies of recreational physical activity in high-income countries, <ref type="bibr" target="#b26">28,</ref><ref type="bibr" target="#b27">29</ref> we did not observe any adverse effects of physical activity on our outcomes even in the approximately 9000 participants who reported over 2500 minutes per week of moderate intensity physical activity (equivalent to 17 times that of physical activity guidelines).</s><s xml:id="_UtmR84a">Therefore, participating at even low physical activity confers benefit (30 minutes per day for 5 days a week), and the benefit continues to increase up to high total physical activity.</s><s xml:id="_hEsGtEZ">The affordability of other CVD interventions such as consuming fruits and vegetables, <ref type="bibr" target="#b28">30</ref> and generic CVD drugs is beyond the reach of many people in low-income and middle-income countries; 31 however, physical activity represents a lowcost approach to CVD prevention .</s></p><p xml:id="_34TpQPs"><s xml:id="_5rqXQ75">When stratified by country income level, there was a consistent reduction of risk with increasing physical activity.</s><s xml:id="_Vp7W9UB">In high-income countries, meeting the physical activity guidelines was associated with a 30% lower risk for mortality, which is lower than the 11% reported in a meta-analysis of walking from a study done predominantly in high-income countries. <ref type="bibr" target="#b11">12</ref></s><s xml:id="_5CJkXZt">However, this earlier study did not include participants in the high physical activity range (&gt;3000 MET × minutes per week), in whom we found a continued benefit with increasing physical activity.</s><s xml:id="_BtjDhTP">Studies in Iran and China <ref type="bibr" target="#b30">32,</ref><ref type="bibr" target="#b31">33</ref> also reported physical activity to be significantly associated with lower mortality in a dose-dependent manner.</s><s xml:id="_Sn65kwP">Notably, Matthews and colleagues <ref type="bibr" target="#b31">33</ref> reported an HR of 0•61 (95% CI 0•51-0•73) at the highest physical activity of the Chinese women, which is similar to our HR of 0•65 (0•60-0•71).</s><s xml:id="_sXBP89s">These findings are consistent with what we found in the lower-middle-income category of countries, of which Iran and China accounted for by far the most participants in our lower-middle-income countries.</s></p><p xml:id="_58BNsTD"><s xml:id="_5tyjPfC">Higher physical activity was associated with a lower risk of mortality plus major CVD in higher-income and uppermiddle-income countries compared with lower-middleincome and low-income countries for both total and recreational physical activity; differences with respect to non-recreational physical activity were less clear.</s><s xml:id="_mfAWDXS">It is unclear why recreational physical activity might be less effective in the lower-middle-income and low-income countries; however, few participants from the countries participated in any recreational physical activity and so these findings could be swayed by a few participants who are atypical of the general populations in poorer countries.</s></p><p xml:id="_XGZYdDX"><s xml:id="_KVEHpSd">Few studies have assessed the association of nonrecreational physical activity with outcomes.</s><s xml:id="_Np8Zugf">The available studies are small and report inconsistent results. <ref type="bibr" target="#b11">12,</ref><ref type="bibr" target="#b32">[34]</ref><ref type="bibr" target="#b33">[35]</ref></s><s xml:id="_GdZKtCK">]<ref type="bibr" target="#b34">[36]</ref><ref type="bibr" target="#b35">[37]</ref><ref type="bibr" target="#b36">[38]</ref> Higher recreational and non-recreational physical activity were independently associated with lower risk with our composite of all-cause mortality plus major CVD, indicating that physical activity of any type is beneficial.</s><s xml:id="_BWUgDRx">Of note, high physical activity was only possible in those individuals participating in non-recreational physical activity.</s><s xml:id="_rRqYv6x">Indeed, only 2•9% of our study population participated in high physical activity (≥3000 MET × minutes per week or ≥750 minutes per week of moderate intensity physical activity) that derived exclusively from rec reational physical activity compared with 37•9% of participants who attained this through non-recreational physical activity.</s><s xml:id="_3f2TZve">This reflects the challenges inherent with participating in high recreational physical activity in that it is, by definition, done during discretionary hours of the day outside of occupational and domestic duties.</s><s xml:id="_BJemfv6">By contrast, incorporating physical activity into a daily lifestyle whether through active transportation, occu pation, or domestic duties has the potential to achieve higher physical activity that is associated with even lower risk for mortality and CVD events.</s></p><p xml:id="_RGckgze"><s xml:id="_vqZQayN">To address concerns related to reverse causality, we excluded individuals with known CVD and then did a sensitivity analysis further excluding those who had events within the first 2 years of follow-up.</s><s xml:id="_zrsa8FX">Our results were unchanged for our main study outcomes.</s><s xml:id="_EFqmWBW">We also did subgroup analyses stratified by sex, age, BMI, smoking, presence of hypertension, and presence of diabetes, and observed consistent results.</s><s xml:id="_b3QydZC">We also observed that increasing physical activity was associated with reduced CVD and non-CVD mortality.</s><s xml:id="_drMqfRR">Regular physical activity is associated with lower mortality from some cancers <ref type="bibr" target="#b26">28,</ref><ref type="bibr" target="#b32">34,</ref><ref type="bibr" target="#b34">36,</ref><ref type="bibr" target="#b37">39</ref> and respiratory conditions. <ref type="bibr" target="#b38">40</ref></s><s xml:id="_w3EpjTr">With continued follow-up, we anticipate accruing enough events to reliably investigate the effects of physical activity on specific categories of non-CVD mortality.</s></p><p xml:id="_sAZsbfX"><s xml:id="_Ec5VpZe">Our study had several limitations.</s><s xml:id="_BjpD8DQ">Although physical activity defined from the self-reported IPAQ modestly overestimates physical activity, it demonstrates good reliability and moderate validity compared with accelerometers such that higher IPAQ values correspond to higher physical activity measured by accelerometers, thus providing good internal validity. <ref type="bibr" target="#b14">15,</ref><ref type="bibr" target="#b39">41,</ref><ref type="bibr" target="#b40">42</ref></s><s xml:id="_4tx3FAp">If physical activity is overestimated by the IPAQ, then the potential benefits of physical activity could be more marked and might occur at lower physical activity than reported here.</s><s xml:id="_G7VDtWV">The IPAQ has been tested across a range of countries similar to the PURE study <ref type="bibr" target="#b14">15</ref> and the use of self-reported measures for assessing physical activity in large studies is considered acceptable in low-resource settings. <ref type="bibr" target="#b41">43</ref></s><s xml:id="_ftP2gMu">lthough it was not feasible to collect a proportionate sampling of the world's population, our selection of countries and communities ensured that our population was typical of the regions from which participants were recruited with only modest differences compared with national data (appendix). <ref type="bibr" target="#b42">44</ref></s><s xml:id="_S54F8W4">Although we did not recruit a random sample of individuals, our approach minimised biases in selection of individuals once the communities were identified.</s><s xml:id="_n5fe98M">Given the range of countries across five continents at different economic levels, the large number of communities, and the large size of our study, our results are globally applicable.</s><s xml:id="_3HNA3WX">Given our method of event ascertainment, it is possible that some events might have been misclassified.</s><s xml:id="_RqQWZpz">However, we believe this potential misclassification to include few events, as most events were ascertained using supporting documents, standard definitions, and adjudication using standard definitions providing high confidence in the validity.</s><s xml:id="_EVeut9f">Lastly, in such a large study, it is not uncommon to report low p values that might not be clinically rele vant, therefore p values should be interpreted with caution unless they are extreme (p&lt;0•001).</s><s xml:id="_DC7wzmK">Given the magni tude and consistency of the effects observed across the different analyses, we are confident in our main findings.</s></p><p xml:id="_vq9AaZr"><s xml:id="_j8YwqhV">Our findings demonstrate that physical activity (both recreational and non-recreational) is associated with a lower risk for mortality and major CVD events, which was independent of the type of physical activity and other risk factors.</s><s xml:id="_aUuDXuA">This finding was seen in all major regions of the world and various country economic levels.</s><s xml:id="_9xmz8KH">In particular, we demonstrate that increasing physical activity is associated with lower risk in lower-middleincome countries and low-income countries.</s><s xml:id="_8uahFdk">Even meeting the physical activity guidelines such as walking for as little as 30 minutes on most days of the week had a substantial benefit, and higher physical activity (up to and beyond 17 times the recommended physical activity guidelines) were associated with even lower risks.</s><s xml:id="_yJemwVp">As participating in physical activity (esp ecially in daily life) is inexpensive, physical activity is a low-cost approach to reducing deaths and CVD that is applicable globally with large potential effect.</s><s xml:id="_82GMW52">The results of our study provide robust evidence to support public health interventions to increase all forms of physical activity in countries of different socioeconomic circumstances. <ref type="bibr" target="#b43">45</ref></s><s xml:id="_ZHnQDt2">ntributors SAL wrote the analysis plans and had the primary responsibility for writing this paper.</s><s xml:id="_YU7BGKx">SY designed and supervised the study, data analysis, interpreted the data and reviewed and commented on drafts.</s></p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head>Figure 1 :Favours</head><label>1</label><figDesc><div><p xml:id="_htpCenR"><s xml:id="_fy9rcXP">Figure1: Hazard ratios and 95% CI for all-cause mortality and major CVD, all-cause mortality, or major CVD by level of physical activity Data adjusted for age, sex, education, country income level, urban or rural residency, family history of CVD, and smoking status; taking into account household, community, and country clustering.</s><s xml:id="_bGcPXRp">There were 3155 events for all-cause mortality and major CVD, 2041 events for all-cause mortality, and 1723 events for major CVD.</s><s xml:id="_2mzFfEu">The p values of the first column show the significance of each comparison.</s><s xml:id="_4unsQYp">p values of the second column show the significance of the overall effect of physical activity.</s><s xml:id="_wPacGfU">Low physical activity=&lt;600 MET × min per week.</s><s xml:id="_j8fEgdK">Moderate physical activity=600-3000 MET × min per week.</s><s xml:id="_7fpubuE">High physical activity=&gt;3000 MET × min per week.</s><s xml:id="_Zz2R2xN">CVD=cardiovascular disease.</s><s xml:id="_5fPbefu">Major CVD=CVD mortality plus incident myocardial infarction, stroke, or heart failure.</s><s xml:id="_sJhz2F5">MET=metabolic equivalents.</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_2"><head>Figure 3 :</head><label>3</label><figDesc><div><p xml:id="_cyuZMxw"><s xml:id="_ugWSCtY">Figure 3: Comparison of physical activity and mortality and major CVD (A) Adjusted HR (black line) and 95% CI (red lines) for mortality and major CVD compared with total physical activity.</s><s xml:id="_jp9mJmc">(B) Adjusted HR for mortality and major CVD compared with recreational physical activity.</s><s xml:id="_bTxHpC3">(C) Adjusted HR for mortality and major CVD compared with non-recreational physical activity.</s><s xml:id="_NHjzGZ7">Models were adjusted for age, sex, education, country income level, urban or rural residency, family history of CVD, and smoking status, taking into account household, community, and country clustering.</s><s xml:id="_nShZ5uD">Recreational physical activity was truncated at 3000 MET × min per week and 750 min per week of moderate intensity physical activity because of sparse observations above that point.</s><s xml:id="_NYBhWtF">CVD=cardiovascular disease.</s><s xml:id="_jZHNQNH">MET=metabolic equivalents.</s><s xml:id="_thw6DEJ">HR=hazard ratio.</s><s xml:id="_EGgExFU">Major CVD=CVD mortality plus incident myocardial infarction, stroke, or heart failure.</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_3"><head>Figure 4 :</head><label>4</label><figDesc><div><p xml:id="_qMrTgpd"><s xml:id="_Qj3QzAA">Figure 4: Comparison of physical activity with mortality and major CVD stratified by country income level (A) Total physical activity.</s><s xml:id="_D2GQ3gw">(B) Recreational physical activity.</s><s xml:id="_PEkDJnR">(C) Non-recreational physical activity.</s><s xml:id="_7METGjD">Models were adjusted for age, sex, education, country income level, urban or rural residency, family history of CVD, and smoking status, taking into account household, community, and country clustering.</s><s xml:id="_Mc4q2sE">CVD=cardiovascular disease.</s><s xml:id="_R3TAQW7">HIC + UMIC = high-income countries plus upper-middle-income countries.</s><s xml:id="_gZahYMb">LMIC + LIC=lower-middle-income countries plus low-income countries.</s><s xml:id="_qReuE3d">Major CVD=CVD mortality plus incident myocardial infarction, stroke, or heart failure.</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_4"><figDesc><div><p xml:id="_CMeVYeR"><s xml:id="_vyw9fRH">(0•89-1.10) 0•94 (0•81-1•08) 0•94 (0•82-1.07)</s><s xml:id="_GSFP5ED">High physical activity ‡ 0•92 (0•82-1.02)</s><s xml:id="_WjHSm9X">0•79 (0•68-0•92) 0•94 (0•83-1.08)or</s><s xml:id="_MWTRkH4">hazard ratio (95%CI</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_5"><head>PURE</head><figDesc><div><p xml:id="_UFqMbuZ"><s xml:id="_593zJsY">Project Office Staff, National Coordinators, Investigators, and Key Staff Project Office (Population Health Research Institute, Hamilton Health Sciences and McMaster University, Hamilton, Canada): S Yusuf (National Coordinator, Principal Investigator).</s><s xml:id="_P88A8Yg">S Rangarajan (Project Manager); K K Teo, C K Chow, M O'Donnell, A Mente, D Leong, A Smyth, P Joseph, S Islam (Statistician), M Zhang (Statistician), W Hu (Statistician), C Ramasundarahettige (Statistician), G Wong (Statistician), S Bangdiwala, L Dyal, A Casanova, M Dehghan (Nutritionist), G Lewis, A Aliberti, A Arshad, A Reyes, A Zaki, B Lewis, B Zhang, D Agapay, D Hari, E Milazzo, E Ramezani, F Hussain, F Shifaly, G McAlpine, I Kay, J Lindeman, J Rimac, J Swallow,</s></p></div></figDesc></figure>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" xml:id="foot_0"><p xml:id="_cxgUjBc"><s xml:id="_tb375BT">www.thelancet.com</s><s xml:id="_X6HarjK">Vol 390 December 16, 2017</s></p></note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" xml:id="foot_1"><p xml:id="_H2abwwE"><s xml:id="_kUcwJhF">www.thelancet.com</s><s xml:id="_2zX5xTQ">Vol 390 December 16, 2017</s></p></note>
		</body>
		<back>

			<div type="acknowledgement">
<div><head xml:id="_yUqEKWZ">Acknowledgments</head><p xml:id="_wSTRgPD"><s xml:id="_tv7jFKX">SAL holds the <rs type="funder">Pfizer/Heart</rs> and <rs type="funder">Stroke Foundation Chair in Cardiovascular Prevention at St Paul's Hospital</rs>.</s><s xml:id="_gh2PM4J">SY is supported by the <rs type="funder">Mary W Burke</rs> endowed chair of the <rs type="funder">Heart and Stroke Foundation of Ontario</rs>.</s></p></div>
			</div>
			<div type="funding">
<div><head xml:id="_D6f452n">Funding sources</head><p xml:id="_JFjEjtN"><s xml:id="_cRncpCM">The <rs type="projectName">PURE Study</rs> is an investigator-initiated study that is funded by the <rs type="funder">Population Health Research Institute</rs>, the <rs type="funder">Canadian Institutes of Health Research, Heart and Stroke Foundation of Ontario</rs>, Support from <rs type="funder">CIHR's Strategy for Patient Oriented Research</rs>, through the <rs type="funder">Ontario SPOR Support Unit</rs> and the <rs type="funder">Ontario Ministry of Health and Long-Term Care</rs>, and through unrestricted grants from several pharmaceutical companies with major contributions from <rs type="funder">AstraZeneca (Canada)</rs>, <rs type="funder">Sanofi-Aventis (France and Canada)</rs>, <rs type="funder">Boehringer Ingelheim (Germany and Canada)</rs>, <rs type="funder">Servier</rs>, and <rs type="funder">GSK</rs>, and additional contributions from <rs type="funder">Novartis</rs> and <rs type="funder">King Pharma</rs> and from various national or local organisations in participating countries.</s><s xml:id="_uY9m7QE">These include <rs type="funder">Fundacion ECLA</rs>, Argentina; <rs type="funder">Independent University, Bangladesh</rs> and <rs type="funder">Mitra and Associates, Bangladesh</rs>; <rs type="funder">Unilever Health Institute, Brazil</rs>; <rs type="funder">Public Health Agency of Canada</rs> and <rs type="funder">Champlain Cardiovascular Disease Prevention Network, Canada</rs>; <rs type="funder">Universidad de la Frontera</rs>, Chile; <rs type="funder">National Center for Cardiovascular Diseases, China</rs>; Colciencias, Columbia, grant number <rs type="grantNumber">6566-04-18062</rs>; <rs type="funder">Indian Council of Medical Research, India</rs>; <rs type="funder">Ministry of Science, Technology and Innovation of Malaysia</rs> grant number <rs type="grantNumber">100 -IRDC / BIOTEK 16/6/21 (13/2007</rs>), grant number <rs type="grantNumber">07-05-IFN-BPH 010</rs>, <rs type="funder">Ministry of Higher Education of Malaysia</rs> grant number <rs type="grantNumber">600 -RMI/LRGS/5/3 (2/2011</rs>), <rs type="funder">Universiti Teknologi MARA, Universiti Kebangsaan, Malaysia</rs> (<rs type="grantNumber">UKM-Hejim-Komuniti-15-2010</rs>); the <rs type="funder">United Nations Relief and Works Agency for Palestine Refugees in the Near East (UNRWA)</rs>, occupied <rs type="funder">Palestinian territory</rs>; <rs type="funder">International Development Research Centre (IDRC)</rs>, <rs type="funder">Canada</rs>; <rs type="funder">Philippine Council for Health Research &amp; Development (PCHRD), Philippines</rs>; <rs type="funder">Polish Ministry of Science and Higher Education</rs> grant number <rs type="grantNumber">290/W-PURE/2008/0</rs>, <rs type="funder">Wroclaw Medical University, Poland</rs>; The <rs type="funder">Deanship of Scientific Research at King Saud University, Riyadh, Saudi Arabia</rs> (Research group number: <rs type="grantNumber">RG -1436-013</rs>); The <rs type="funder">North-West University</rs>, <rs type="funder">SANPAD (SA</rs> and <rs type="funder">Netherlands Programme for Alternative Development)</rs>, <rs type="funder">South Africa</rs>, <rs type="funder">National Research Foundation</rs>, <rs type="funder">South Africa</rs>, <rs type="funder">Medical Research Council of SA, South Africa</rs>, The <rs type="funder">SA Sugar Association (SASA)</rs>, <rs type="funder">South Africa, Faculty of Community and Health Sciences (UWC), South Africa</rs>; grants from the Swedish state under the <rs type="funder">Agreement concerning research and education of doctors</rs>; the <rs type="funder">Swedish Heart and Lung Foundation, Sweden</rs>; the <rs type="funder">Swedish Research Council, Sweden</rs>; the <rs type="funder">Swedish Council for Health, Sweden, Working Life and Welfare, Sweden</rs>, <rs type="funder">King Gustaf V</rs> and <rs type="funder">Queen Victoria Freemasons Foundation, Sweden</rs>, <rs type="funder">AFA Insurance, Sweden</rs>, <rs type="funder">Swedish Council for Working Life and Social Research, Sweden</rs>, <rs type="funder">Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning, Sweden</rs>, grant from the <rs type="funder">Swedish state under (LäkarUtbildningsAvtalet) Agreement</rs>, grant from the <rs type="funder">Västra Götaland Region (FOUU)</rs>, <rs type="funder">Sweden</rs>; <rs type="funder">Metabolic Syndrome Society</rs>, <rs type="funder">AstraZeneca, Turkey</rs>, <rs type="funder">Sanofi-Aventis</rs>, <rs type="funder">Turkey</rs>; <rs type="funder">Sheikh Hamdan Bin Rashid Al Maktoum Award For Medical Sciences and Dubai Health Authority, Dubai, United Arab Emirates</rs>.</s></p></div>
			</div>
			<listOrg type="funding">
				<org type="funded-project" xml:id="_aU7Fpy8">
					<orgName type="project" subtype="full">PURE Study</orgName>
				</org>
				<org type="funding" xml:id="_ZjVWYZb">
					<idno type="grant-number">6566-04-18062</idno>
				</org>
				<org type="funding" xml:id="_6Qpd4p5">
					<idno type="grant-number">100 -IRDC / BIOTEK 16/6/21 (13/2007</idno>
				</org>
				<org type="funding" xml:id="_vS68TXk">
					<idno type="grant-number">07-05-IFN-BPH 010</idno>
				</org>
				<org type="funding" xml:id="_98QbWwh">
					<idno type="grant-number">600 -RMI/LRGS/5/3 (2/2011</idno>
				</org>
				<org type="funding" xml:id="_PRQrgXh">
					<idno type="grant-number">UKM-Hejim-Komuniti-15-2010</idno>
				</org>
				<org type="funding" xml:id="_aCJhZk9">
					<idno type="grant-number">290/W-PURE/2008/0</idno>
				</org>
				<org type="funding" xml:id="_b7bBkU8">
					<idno type="grant-number">RG -1436-013</idno>
				</org>
			</listOrg>
			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0" xml:id="_4Jm5Z7e"><p xml:id="_qBKAbDg"><s xml:id="_MFNwZWd">SR coordinated the worldwide study and reviewed and commented on drafts.</s><s xml:id="_B3FfTrs">WH did the analysis.</s><s xml:id="_qwsaHCJ">KT, WH, AC, DL, and DG reviewed and commented on the data analysis and drafts.</s><s xml:id="_9AFENjQ">All other authors coordinated the study in their respective countries and provided comments on drafts of the manuscript.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_cnCkbJE">Declarations of interest</head><p xml:id="_mcduysD"><s xml:id="_t8tsm3S">We declare no competing interests.</s></p></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main" xml:id="_TVq4zSE">Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013</title>
		<idno type="DOI">10.1016/s0140-6736(14)61682-2</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_WvSC3R3">Lancet</title>
		<imprint>
			<biblScope unit="volume">385</biblScope>
			<biblScope unit="page" from="117" to="171" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 2015; 385: 117-71.</note>
</biblStruct>

<biblStruct xml:id="b1">
	<monogr>
		<title level="m" type="main" xml:id="_KVVgKJS">The global economic burden of noncommunicable diseases</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">E</forename><surname>Bloom</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">T</forename><surname>Cafiero</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Jané-Llopis</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2011">2011</date>
			<publisher>World Economic Forum</publisher>
			<pubPlace>Geneva</pubPlace>
		</imprint>
	</monogr>
	<note type="raw_reference">Bloom DE, Cafiero ET, Jané-Llopis E, et al. The global economic burden of noncommunicable diseases. Geneva: World Economic Forum, 2011.</note>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main" xml:id="_bfXEgFX">Demographic and epidemiologic drivers of global cardiovascular mortality</title>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">A</forename><surname>Roth</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">H</forename><surname>Forouzanfar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">E</forename><surname>Moran</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_m3c8zEh">N Engl J Med</title>
		<imprint>
			<biblScope unit="volume">372</biblScope>
			<biblScope unit="page" from="1333" to="1341" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Roth GA, Forouzanfar MH, Moran AE, et al. Demographic and epidemiologic drivers of global cardiovascular mortality. N Engl J Med 2015; 372: 1333-41.</note>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main" xml:id="_9Ak8mmA">The Global Burden of Disease Study and the preventable burden of NCD</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">P</forename><surname>Benziger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">A</forename><surname>Roth</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">E</forename><surname>Moran</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.gheart.2016.10.024</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_tJ6TYfU">Glob Heart</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="page" from="393" to="397" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Benziger CP, Roth GA, Moran AE. The Global Burden of Disease Study and the preventable burden of NCD. Glob Heart 2016; 11: 393-97.</note>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main" xml:id="_MP43vQu">Global public health: a scorecard</title>
		<author>
			<persName><forename type="first">R</forename><surname>Beaglehole</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Bonita</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_v4qXgJP">Lancet</title>
		<imprint>
			<biblScope unit="volume">372</biblScope>
			<biblScope unit="page" from="1988" to="1996" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Beaglehole R, Bonita R. Global public health: a scorecard. Lancet 2008; 372: 1988-96.</note>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main" xml:id="_zmPaEVQ">Progress in physical activity over the Olympic quadrennium</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">F</forename><surname>Sallis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Bull</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Guthold</surname></persName>
		</author>
		<idno type="DOI">10.1016/s0140-6736(16)30581-5</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_YamcATg">Lancet</title>
		<imprint>
			<biblScope unit="volume">388</biblScope>
			<biblScope unit="page" from="1325" to="1336" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Sallis JF, Bull F, Guthold R, et al. Progress in physical activity over the Olympic quadrennium. Lancet 2016; 388: 1325-36.</note>
</biblStruct>

<biblStruct xml:id="b6">
	<monogr>
		<title level="m" xml:id="_YnnYRpm">Sixty-sixth World Health Assembly. Follow-up to the political declaration of the high-level meeting of the General Assembly on the Prevention and Control of Non-communicable Diseases: United Nations</title>
		<imprint>
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Sixty-sixth World Health Assembly. Follow-up to the political declaration of the high-level meeting of the General Assembly on the Prevention and Control of Non-communicable Diseases: United Nations, 2013.</note>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main" xml:id="_RceEERr">Association of physical activity with all-cause and cardiovascular mortality: a systematic review and meta-analysis</title>
		<author>
			<persName><forename type="first">M</forename><surname>Nocon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Hiemann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Muller-Riemenschneider</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Thalau</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Roll</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">N</forename><surname>Willich</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_AtmCBqU">Eur J Cardiovasc Prev Rehabil</title>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="page" from="239" to="246" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Nocon M, Hiemann T, Muller-Riemenschneider F, Thalau F, Roll S, Willich SN. Association of physical activity with all-cause and cardiovascular mortality: a systematic review and meta-analysis. Eur J Cardiovasc Prev Rehabil 2008; 15: 239-46.</note>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main" xml:id="_7k9U78D">Effect of physical inactivity on major non-communicable diseases worldwide: an analysis of burden of disease and life expectancy</title>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">M</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">J</forename><surname>Shiroma</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Lobelo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Puska</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">N</forename><surname>Blair</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">T</forename><surname>Katzmarzyk</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_4YzKbCF">Lancet</title>
		<imprint>
			<biblScope unit="volume">380</biblScope>
			<biblScope unit="page" from="219" to="229" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Lee IM, Shiroma EJ, Lobelo F, Puska P, Blair SN, Katzmarzyk PT. Effect of physical inactivity on major non-communicable diseases worldwide: an analysis of burden of disease and life expectancy. Lancet 2012; 380: 219-29.</note>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main" xml:id="_JcECWsD">Review of the epidemiological evidence for physical activity and health from low-and middle-income countries</title>
		<author>
			<persName><forename type="first">K</forename><surname>Milton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Macniven</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Bauman</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_6RNd2v8">Glob Pub Health</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="page" from="369" to="381" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Milton K, Macniven R, Bauman A. Review of the epidemiological evidence for physical activity and health from low-and middle-income countries. Glob Pub Health 2014; 9: 369-81.</note>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main" xml:id="_hS2c6ze">Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study</title>
		<author>
			<persName><forename type="first">S</forename><surname>Yusuf</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Hawken</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Ounpuu</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_utFeced">Lancet</title>
		<imprint>
			<biblScope unit="volume">364</biblScope>
			<biblScope unit="page" from="937" to="952" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Yusuf S, Hawken S, Ounpuu S, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 2004; 364: 937-52.</note>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main" xml:id="_7gBRpjJ">Systematic review and meta-analysis of reduction in all-cause mortality from walking and cycling and shape of dose response relationship</title>
		<author>
			<persName><forename type="first">P</forename><surname>Kelly</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Kahlmeier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Gotschi</surname></persName>
		</author>
		<idno type="DOI">10.1186/s12966-014-0132-x</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_DDXwH6f">Int J Behav Nutr Phys Act</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="page">132</biblScope>
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Kelly P, Kahlmeier S, Gotschi T, et al. Systematic review and meta-analysis of reduction in all-cause mortality from walking and cycling and shape of dose response relationship. Int J Behav Nutr Phys Act 2014; 11: 132.</note>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main" xml:id="_7VqT2U5">Association between occupational physical activity and myocardial infarction: a prospective cohort study</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Johnsen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Alfredsson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Knutsson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">J</forename><surname>Westerholm</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">I</forename><surname>Fransson</surname></persName>
		</author>
		<idno type="DOI">10.1136/bmjopen-2016-012692</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_DyKhr3F">BMJ Open</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="page">e012692</biblScope>
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Johnsen AM, Alfredsson L, Knutsson A, Westerholm PJ, Fransson EI. Association between occupational physical activity and myocardial infarction: a prospective cohort study. BMJ Open 2016; 6: e012692.</note>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main" xml:id="_A2utUhs">The Prospective Urban Rural Epidemiology (PURE) study: examining the impact of societal influences on chronic noncommunicable diseases in low-, middle-, and high-income countries</title>
		<author>
			<persName><forename type="first">K</forename><surname>Teo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">K</forename><surname>Chow</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Vaz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Rangarajan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Yusuf</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.ahj.2009.04.019</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_hvV2TvA">Am Heart J</title>
		<imprint>
			<biblScope unit="volume">158</biblScope>
			<biblScope unit="page" from="1" to="7" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Teo K, Chow CK, Vaz M, Rangarajan S, Yusuf S. The Prospective Urban Rural Epidemiology (PURE) study: examining the impact of societal influences on chronic noncommunicable diseases in low-, middle-, and high-income countries. Am Heart J 2009; 158: 1-7.</note>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main" xml:id="_TenUU2Q">International physical activity questionnaire: 12-country reliability and validity</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">L</forename><surname>Craig</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">L</forename><surname>Marshall</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Sjostrom</surname></persName>
		</author>
		<idno type="DOI">10.1249/01.mss.0000078924.61453.fb</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_v2PWJS3">Med Sci Sports Exerc</title>
		<imprint>
			<biblScope unit="volume">35</biblScope>
			<biblScope unit="page" from="1381" to="1395" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Craig CL, Marshall AL, Sjostrom M, et al. International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc 2003; 35: 1381-95.</note>
</biblStruct>

<biblStruct xml:id="b15">
	<monogr>
		<idno type="DOI">10.26719/2015.21.6.379</idno>
		<title level="m" xml:id="_dXMvYNn">Global recommendations on physical activity for health</title>
		<meeting><address><addrLine>Geneva</addrLine></address></meeting>
		<imprint>
			<publisher>World Health Organization</publisher>
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
	<note type="raw_reference">World Health Organization. Global recommendations on physical activity for health. Geneva: World Health Organization, 2010.</note>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main" xml:id="_JB3Qf5J">Verbal autopsy of 48 000 adult deaths attributable to medical causes in Chennai (formerly Madras), India</title>
		<author>
			<persName><forename type="first">V</forename><surname>Gajalakshmi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Peto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Kanaka</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Balasubramanian</surname></persName>
		</author>
		<idno type="DOI">10.1186/1471-2458-2-7</idno>
		<ptr target="http://www.ipaq.ki.se/dloads/IPAQ%20LS%20Scoring%20Protocols_Nov05.pdf" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_VjQcp6M">BMC Public Health</title>
		<imprint>
			<biblScope unit="volume">2</biblScope>
			<biblScope unit="page" from="7" to="18" />
			<date type="published" when="2002-01-15">2002. Jan 15, 2017</date>
		</imprint>
	</monogr>
	<note>Guidelines for data processing and analysis of the International Physical Activity Questionnaire (IPAQ)-Short and Long Forms. 2005</note>
	<note type="raw_reference">Gajalakshmi V, Peto R, Kanaka S, Balasubramanian S. Verbal autopsy of 48 000 adult deaths attributable to medical causes in Chennai (formerly Madras), India. BMC Public Health 2002; 2: 7. 18 Guidelines for data processing and analysis of the International Physical Activity Questionnaire (IPAQ)-Short and Long Forms. 2005. http://www.ipaq.ki.se/dloads/IPAQ%20LS%20Scoring%20 Protocols_Nov05.pdf (accessed Jan 15, 2017).</note>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main" xml:id="_DDeRnmA">A distribution-free k-sample test against ordered alternatives</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">R</forename><surname>Jonckheere</surname></persName>
		</author>
		<idno type="DOI">10.2307/2333011</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_Kye4z2K">Biometrika</title>
		<imprint>
			<biblScope unit="volume">41</biblScope>
			<biblScope unit="page" from="133" to="145" />
			<date type="published" when="1954-12-16">1954. December 16, 2017</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Jonckheere AR. A distribution-free k-sample test against ordered alternatives. Biometrika 1954; 41: 133-45. www.thelancet.com Vol 390 December 16, 2017</note>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main" xml:id="_WhEjSw2">The asymptotic normality and consistency of Kendall&apos;s test against trend, when ties are present in one ranking</title>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">J</forename><surname>Terpstra</surname></persName>
		</author>
		<idno type="DOI">10.1016/s1385-7258(52)50043-x</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_8VktuFB">Indag Math</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="page" from="327" to="333" />
			<date type="published" when="1952">1952</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Terpstra TJ. The asymptotic normality and consistency of Kendall&apos;s test against trend, when ties are present in one ranking. Indag Math 1952; 14: 327-33.</note>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main" xml:id="_eypZKSh">Tests for linear trends in proportions and frequencies</title>
		<author>
			<persName><forename type="first">P</forename><surname>Armitage</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_QPsPVdz">Biometrics</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="page" from="375" to="386" />
			<date type="published" when="1955">1955</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Armitage P. Tests for linear trends in proportions and frequencies. Biometrics 1955; 11: 375-86.</note>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main" xml:id="_R8jX4Sp">Some methods of strengthening the common 2 x tests</title>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">G</forename><surname>Cochran</surname></persName>
		</author>
		<idno type="DOI">10.2307/3001616</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_qhkATdv">Biometrics</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="page" from="417" to="451" />
			<date type="published" when="1954">1954</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Cochran WG. Some methods of strengthening the common 2 x tests. Biometrics 1954; 10: 417-51.</note>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main" xml:id="_ypakPXt">Estimating standard errors for life expectancies based on complex survey data with mortality follow-up: a case study using the National Health Interview Survey Linked Mortality Files</title>
		<author>
			<persName><forename type="first">N</forename><surname>Schenker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">L</forename><surname>Parsons</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">A</forename><surname>Lochner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Wheatcroft</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">R</forename><surname>Pamuk</surname></persName>
		</author>
		<idno type="DOI">10.1002/sim.4219</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_kd2wQuM">Stat Med</title>
		<imprint>
			<biblScope unit="volume">30</biblScope>
			<biblScope unit="page" from="1302" to="1311" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Schenker N, Parsons VL, Lochner KA, Wheatcroft G, Pamuk ER. Estimating standard errors for life expectancies based on complex survey data with mortality follow-up: a case study using the National Health Interview Survey Linked Mortality Files. Stat Med 2011; 30: 1302-11.</note>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main" xml:id="_R28VFSe">Cox-type regression analysis for large numbers of small groups of correlated failure time observations</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">W</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">J</forename><surname>Wei</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">A</forename><surname>Amato</surname></persName>
		</author>
		<idno type="DOI">10.1007/978-94-015-7983-4_14</idno>
	</analytic>
	<monogr>
		<title level="m" xml:id="_pyrkuRy">Survival analysis: state of the art</title>
		<editor>
			<persName><forename type="first">J</forename><forename type="middle">P</forename><surname>Klein</surname></persName>
		</editor>
		<editor>
			<persName><forename type="first">P</forename><forename type="middle">K</forename><surname>Goel</surname></persName>
		</editor>
		<meeting><address><addrLine>Dordrecht, Netherlands</addrLine></address></meeting>
		<imprint>
			<publisher>Kluwer Academic Publishers</publisher>
			<date type="published" when="1992">1992</date>
			<biblScope unit="page" from="237" to="247" />
		</imprint>
	</monogr>
	<note type="raw_reference">Lee EW, Wei LJ, Amato DA. Cox-type regression analysis for large numbers of small groups of correlated failure time observations. In: Klein JP, Goel PK, eds. Survival analysis: state of the art. Dordrecht, Netherlands: Kluwer Academic Publishers, 1992: 237-47.</note>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main" xml:id="_R2nAZeZ">Cox Regression analysis of multivariate failure time data: the marginal approach</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">Y</forename><surname>Lin</surname></persName>
		</author>
		<idno type="DOI">10.1002/sim.4780132105</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_cKWNEPd">Stat Med</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="page" from="2233" to="2247" />
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Lin DY. Cox Regression analysis of multivariate failure time data: the marginal approach. Stat Med 1994; 13: 2233-47.</note>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main" xml:id="_pG66cb9">Attributable fraction functions for censored event times</title>
		<author>
			<persName><forename type="first">L</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">Y</forename><surname>Lin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Zeng</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_eQWQR5W">Biometrika</title>
		<imprint>
			<biblScope unit="volume">97</biblScope>
			<biblScope unit="page" from="713" to="726" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Chen L, Lin DY, Zeng D. Attributable fraction functions for censored event times. Biometrika 2010; 97: 713-26.</note>
</biblStruct>

<biblStruct xml:id="b25">
	<monogr>
		<title level="m" type="main" xml:id="_dYcCcHh">Regression modeling strategies: with applications to linear models, logistic regression, and survival analysis</title>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">E</forename><surname>Harrell</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2001">2001</date>
			<publisher>Springer-Verlag</publisher>
			<pubPlace>New York; New York</pubPlace>
		</imprint>
	</monogr>
	<note type="raw_reference">Harrell FE. Regression modeling strategies: with applications to linear models, logistic regression, and survival analysis. New York: Springer-Verlag New York, 2001.</note>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main" xml:id="_n6c4f3T">Leisure time physical activity and mortality: a detailed pooled analysis of the dose-response relationship</title>
		<author>
			<persName><forename type="first">H</forename><surname>Arem</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">C</forename><surname>Moore</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Patel</surname></persName>
		</author>
		<idno type="DOI">10.1001/jamainternmed.2015.0533</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_jmw6hU8">JAMA Intern Med</title>
		<imprint>
			<biblScope unit="volume">175</biblScope>
			<biblScope unit="page" from="959" to="967" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Arem H, Moore SC, Patel A, et al. Leisure time physical activity and mortality: a detailed pooled analysis of the dose-response relationship. JAMA Intern Med 2015; 175: 959-67.</note>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main" xml:id="_BCPQTNk">Leisure time physical activity of moderate to vigorous intensity and mortality: a large pooled cohort analysis</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">C</forename><surname>Moore</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">V</forename><surname>Patel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">E</forename><surname>Matthews</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_Vmtvv3j">PLoS Med</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="page">1001335</biblScope>
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Moore SC, Patel AV, Matthews CE, et al. Leisure time physical activity of moderate to vigorous intensity and mortality: a large pooled cohort analysis. PLoS Med 2012; 9: e1001335.</note>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main" xml:id="_BCRx8V4">Availability, affordability, and consumption of fruits and vegetables in 18 countries across income levels: findings from the Prospective Urban Rural Epidemiology (PURE) study</title>
		<author>
			<persName><forename type="first">V</forename><surname>Miller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Yusuf</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">K</forename><surname>Chow</surname></persName>
		</author>
		<idno type="DOI">10.1016/s2214-109x(16)30186-3</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_mtxqbrv">Lancet Glob Health</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="page" from="695" to="703" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Miller V, Yusuf S, Chow CK, et al. Availability, affordability, and consumption of fruits and vegetables in 18 countries across income levels: findings from the Prospective Urban Rural Epidemiology (PURE) study. Lancet Glob Health 2016; 4: e695-703.</note>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main" xml:id="_GbNDyMu">Availability and affordability of cardiovascular disease medicines and their effect on use in high-income, middle-income, and low-income countries: an analysis of the PURE study data</title>
		<author>
			<persName><forename type="first">R</forename><surname>Khatib</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Mckee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Shannon</surname></persName>
		</author>
		<idno type="DOI">10.1016/s0140-6736(15)00469-9</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_4HW8QTg">Lancet</title>
		<imprint>
			<biblScope unit="volume">387</biblScope>
			<biblScope unit="page" from="61" to="69" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Khatib R, McKee M, Shannon H, et al. Availability and affordability of cardiovascular disease medicines and their effect on use in high-income, middle-income, and low-income countries: an analysis of the PURE study data. Lancet 2016; 387: 61-69.</note>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main" xml:id="_Fa8rQ6N">Impact of body size and physical activity during adolescence and adult life on overall and cause-specific mortality in a large cohort study from Iran</title>
		<author>
			<persName><forename type="first">A</forename><surname>Etemadi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">C</forename><surname>Abnet</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Kamangar</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_KRNMsqD">Eur J Epidemiol</title>
		<imprint>
			<biblScope unit="volume">29</biblScope>
			<biblScope unit="page" from="95" to="109" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Etemadi A, Abnet CC, Kamangar F, et al. Impact of body size and physical activity during adolescence and adult life on overall and cause-specific mortality in a large cohort study from Iran. Eur J Epidemiol 2014; 29: 95-109.</note>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main" xml:id="_FqXkNn2">Influence of exercise, walking, cycling, and overall nonexercise physical activity on mortality in Chinese women</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">E</forename><surname>Matthews</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">L</forename><surname>Jurj</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><forename type="middle">O</forename><surname>Shu</surname></persName>
		</author>
		<idno type="DOI">10.1093/aje/kwm088</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_z5QyAhb">Am J Epidemiol</title>
		<imprint>
			<biblScope unit="volume">165</biblScope>
			<biblScope unit="page" from="1343" to="1350" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Matthews CE, Jurj AL, Shu XO, et al. Influence of exercise, walking, cycling, and overall nonexercise physical activity on mortality in Chinese women. Am J Epidemiol 2007; 165: 1343-50.</note>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main" xml:id="_hUh6m85">Housework reduces all-cause and cancer mortality in Chinese men</title>
		<author>
			<persName><forename type="first">R</forename><surname>Yu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Leung</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Woo</surname></persName>
		</author>
		<idno type="DOI">10.1371/journal.pone.0061529</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_PmstJ98">PLoS One</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page">61529</biblScope>
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Yu R, Leung J, Woo J. Housework reduces all-cause and cancer mortality in Chinese men. PLoS One 2013; 8: e61529.</note>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main" xml:id="_E8rWe8q">Relationship between subdomains of total physical activity and mortality</title>
		<author>
			<persName><forename type="first">H</forename><surname>Besson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>Ekelund</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Brage</surname></persName>
		</author>
		<idno type="DOI">10.1249/mss.0b013e318180bcad</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_Yez8VSZ">Med Sci Sports Exerc</title>
		<imprint>
			<biblScope unit="volume">40</biblScope>
			<biblScope unit="page" from="1909" to="1915" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Besson H, Ekelund U, Brage S, et al. Relationship between subdomains of total physical activity and mortality. Med Sci Sports Exerc 2008; 40: 1909-15.</note>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main" xml:id="_WVpFN6u">Association between domains of physical activity and all-cause, cardiovascular and cancer mortality</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">S</forename><surname>Autenrieth</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Baumert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">E</forename><surname>Baumeister</surname></persName>
		</author>
		<idno type="DOI">10.1007/s10654-010-9517-6</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_6vB3pMj">Eur J Epidemiol</title>
		<imprint>
			<biblScope unit="volume">26</biblScope>
			<biblScope unit="page" from="91" to="99" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Autenrieth CS, Baumert J, Baumeister SE, et al. Association between domains of physical activity and all-cause, cardiovascular and cancer mortality. Eur J Epidemiol 2011; 26: 91-99.</note>
</biblStruct>

<biblStruct xml:id="b35">
	<analytic>
		<title level="a" type="main" xml:id="_BYxqfvG">Effect of intensity and type of physical activity on mortality: results from the Whitehall II cohort study</title>
		<author>
			<persName><forename type="first">S</forename><surname>Sabia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Dugravot</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Kivimaki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Brunner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Shipley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Singh-Manoux</surname></persName>
		</author>
		<idno type="DOI">10.2105/ajph.2011.300257</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_AJUsSRF">Am J Public Health</title>
		<imprint>
			<biblScope unit="volume">102</biblScope>
			<biblScope unit="page" from="698" to="704" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Sabia S, Dugravot A, Kivimaki M, Brunner E, Shipley MJ, Singh-Manoux A. Effect of intensity and type of physical activity on mortality: results from the Whitehall II cohort study. Am J Public Health 2012; 102: 698-704.</note>
</biblStruct>

<biblStruct xml:id="b36">
	<analytic>
		<title level="a" type="main" xml:id="_XBg3vWy">Occupational, commuting, and leisure-time physical activity in relation to cardiovascular mortality among Finnish subjects with hypertension</title>
		<author>
			<persName><forename type="first">G</forename><surname>Hu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Jousilahti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Antikainen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Tuomilehto</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.amjhyper.2007.07.015</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_mKVYrHh">Am J Hypertens</title>
		<imprint>
			<biblScope unit="volume">20</biblScope>
			<biblScope unit="page" from="1242" to="1250" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Hu G, Jousilahti P, Antikainen R, Tuomilehto J. Occupational, commuting, and leisure-time physical activity in relation to cardiovascular mortality among Finnish subjects with hypertension. Am J Hypertens 2007; 20: 1242-50.</note>
</biblStruct>

<biblStruct xml:id="b37">
	<analytic>
		<title level="a" type="main" xml:id="_BzQmNBP">The association of physical activity with all-cause, cardiovascular, and cancer mortalities among older adults</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">Y</forename><surname>Wu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">Y</forename><surname>Hu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">C</forename><surname>Chou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Huang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">J</forename><surname>Chou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">P</forename><surname>Li</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_22785jn">Prev Med</title>
		<imprint>
			<biblScope unit="volume">72</biblScope>
			<biblScope unit="page" from="23" to="29" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Wu CY, Hu HY, Chou YC, Huang N, Chou YJ, Li CP. The association of physical activity with all-cause, cardiovascular, and cancer mortalities among older adults. Prev Med 2015; 72: 23-29.</note>
</biblStruct>

<biblStruct xml:id="b38">
	<analytic>
		<title level="a" type="main" xml:id="_S9dcdHk">Changes in physical activity and all-cause mortality in COPD</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">W</forename><surname>Vaes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Garcia-Aymerich</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">L</forename><surname>Marott</surname></persName>
		</author>
		<idno type="DOI">10.1183/09031936.00023214</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_6eHW9AW">Eur Respir J</title>
		<imprint>
			<biblScope unit="volume">44</biblScope>
			<biblScope unit="page" from="1199" to="1209" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Vaes AW, Garcia-Aymerich J, Marott JL, et al. Changes in physical activity and all-cause mortality in COPD. Eur Respir J 2014; 44: 1199-209.</note>
</biblStruct>

<biblStruct xml:id="b39">
	<analytic>
		<title level="a" type="main" xml:id="_bNM5s4T">The International Prevalence Study on Physical Activity: results from 20 countries</title>
		<author>
			<persName><forename type="first">A</forename><surname>Bauman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Bull</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Chey</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_Y2WmAKE">Int J Behav Nutr Phys Act</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="page">21</biblScope>
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Bauman A, Bull F, Chey T, et al. The International Prevalence Study on Physical Activity: results from 20 countries. Int J Behav Nutr Phys Act 2009; 6: 21.</note>
</biblStruct>

<biblStruct xml:id="b40">
	<analytic>
		<title level="a" type="main" xml:id="_Jytq55a">Validation of the long international physical activity questionnaire: influence of age and language region</title>
		<author>
			<persName><forename type="first">M</forename><surname>Wanner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Probst-Hensch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Kriemler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Meier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Autenrieth</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">W</forename><surname>Martin</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.pmedr.2016.03.003</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_md2EMuG">Prevent Med Rep</title>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="page" from="250" to="256" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Wanner M, Probst-Hensch N, Kriemler S, Meier F, Autenrieth C, Martin BW. Validation of the long international physical activity questionnaire: influence of age and language region. Prevent Med Rep 2016; 3: 250-56.</note>
</biblStruct>

<biblStruct xml:id="b41">
	<analytic>
		<title level="a" type="main" xml:id="_km9Ha3f">Guide to the assessment of physical activity: Clinical and research applications: a scientific statement from the American Heart Association</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">J</forename><surname>Strath</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">A</forename><surname>Kaminsky</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">E</forename><surname>Ainsworth</surname></persName>
		</author>
		<idno type="DOI">10.1161/01.cir.0000435708.67487.da</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_7gG6MR2">Circulation</title>
		<imprint>
			<biblScope unit="volume">128</biblScope>
			<biblScope unit="page" from="2259" to="2279" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Strath SJ, Kaminsky LA, Ainsworth BE, et al. Guide to the assessment of physical activity: Clinical and research applications: a scientific statement from the American Heart Association. Circulation 2013; 128: 2259-79.</note>
</biblStruct>

<biblStruct xml:id="b42">
	<analytic>
		<title level="a" type="main" xml:id="_Csxmy3X">Prospective Urban Rural Epidemiology (PURE) study: baseline characteristics of the household sample and comparative analyses with national data in 17 countries</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">J</forename><surname>Corsi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">V</forename><surname>Subramanian</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">K</forename><surname>Chow</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.ahj.2013.04.019</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_z25BkF6">Am Heart J</title>
		<imprint>
			<biblScope unit="volume">166</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="636" to="646" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Corsi DJ, Subramanian SV, Chow CK, et al. Prospective Urban Rural Epidemiology (PURE) study: baseline characteristics of the household sample and comparative analyses with national data in 17 countries. Am Heart J 2013; 166: 636-46.e4.</note>
</biblStruct>

<biblStruct xml:id="b43">
	<analytic>
		<title level="a" type="main" xml:id="_dMjvrsP">Scaling up physical activity interventions worldwide: stepping up to larger and smarter approaches to get people moving</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">S</forename><surname>Reis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Salvo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Ogilvie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">V</forename><surname>Lambert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Goenka</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">C</forename><surname>Brownson</surname></persName>
		</author>
		<idno type="DOI">10.1016/s0140-6736(16)30728-0</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_v9cVFYw">Lancet</title>
		<imprint>
			<biblScope unit="volume">388</biblScope>
			<biblScope unit="page" from="1337" to="1348" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Reis RS, Salvo D, Ogilvie D, Lambert EV, Goenka S, Brownson RC. Scaling up physical activity interventions worldwide: stepping up to larger and smarter approaches to get people moving. Lancet 2016; 388: 1337-48.</note>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
